Abstract
Neurodevelopmental disorders (NDDs) are often sexually dimorphic, with one sex more affected than the other. This chapter examines the genetic mechanisms underlying sex determination and the neuroendocrine mechanisms underlying sexual differentiation. Research on the development of sex differences in the brain and body focuses on the prenatal, perinatal, and pubertal critical periods of development and how hormones and other neurochemical signals act as epigenetic mechanisms to shape male and female brains and neuroendocrine systems. In addition to genes and hormones, glial cells and the neuroimmune system are involved in sexual differentiation of just about every physiological system in the body. Given that each cell in the body has XX or XY chromosomes, every cell is sexually differentiated. While the focus of this chapter is on the sexual differentiation of the brain and neuroendocrine system and how these sex differences influence the development of NDD), I have also examined sex differences in the cardiovascular system and in energy metabolism which result in sex differences in cardiovascular and metabolic disorders. While the primary events in sexual differentiation occur prenatally and perinatally, puberty is also a period of sexual differentiation and the reorganization of neural and neuroendocrine pathways that occur during the transition from childhood to adulthood. Puberty is also associated with the onset of adolescent NDD, including obesity, anorexia, neuropsychiatric and addictive disorder, as well as disorders of gender identity and role. This chapter also discusses the effect of neurotoxins and endocrine disruptors in the disorders of sex differentiation and in the development of NDD.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Learning Objectives-
The role of genes in sex determination.
-
The role of hormones in sexual differentiation.
-
That sex differences develop during critical periods of development.
-
That genes and hormones are involved in the sexual differentiation of the brain
-
That there is a sexual differentiation of glial cells (astrocytes and microglia) and that these cells are involved in the sex differentiation of the brain and neuroendocrine system.
-
That there are sex differences in brain structure, function and neurochemical pathways that underlie sex differences in NDD.
-
That the sexual differentiation of the hypothalamic-pituitary (neuroendocrine) system results in sex differences in the secretion and actions of hormones throughout the body.
-
That hormones may underlie the sex differences in NDD disorders.
-
That puberty is a critical period for the reorganization of brain and neuroendocrine systems during the transition from childhood to adulthood.
-
That neurotoxins and endocrine-disrupting chemicals in the environment can disrupt sexual differentiation during critical periods of development.
-
Sex differences depend on the XX and XY chromosomes.
-
Sex differences depend on the gonadal steroid hormones, estrogen, and testosterone.
-
Sex differences depend on the sexual differentiation of neurons and neurotransmitter pathways in the hypothalamus and related brain areas: the amygdala, hippocampus, and arcuate nucleus.
-
Sex differences depend on glial cells and gliotransmitters.
Introduction to Sex Differences in Neurodevelopmental Disorders
Anatomical, physiological, and cognitive-behavioral systems in mammalian development all show some form of sexual dimorphism [1,2,3]. Sex differences also occur in susceptibility to disease [4], and among neurological diseases, "virtually every neurodegenerative and neuropsychiatric disease shows some variation, often striking, between males and females" ([5], page 2). Zagni, et al. [6] noted that NDDs occur more often in males, while adult-onset neurological disorders have a higher frequency in females. Neuroendocrine abnormalities may underlie a number of NDDs [7, 8] and this chapter examines the genetic, epigenetic, and neurochemical factors that underlie sex differences in NDDs.
Table 11.1 lists some NDDs, giving estimates of their frequency of occurrence per 100 children [9] and the sex ratio of children with each disorder [10, 11]. In many NDD, the sex ratio may not differ, but the neural and behavioral manifestations of the disorder show sex differences [12, 13]. This chapter describes the process of sex determination and then examines the role of genes, hormones, glial cells, and neuro-immune interactions in sexual differentiation of the brain and nervous system and how these mechanisms regulate sex differences in the development of NDD. The chapter concludes with a discussion of sex differences in NDD at puberty and a discussion of the theories about the causes of sex differences in NDDs.
Sex Determination and Sexual Differentiation
In mammals, sex determination depends on the genes on the sex chromosomes, while sexual differentiation depends on the action of gonadal hormones and other chemical signals, which activate gene expression differentially in each sex. Females have two X chromosomes (46 XX in humans; 40 XX in mice), while males have an X and a Y chromosome (46XY in humans; 40XY in mice). Most of the research has been done on rodents and the ability to make genetically modified mice has enabled sex differences determined by genes and those determined by hormones to be dissociated [3, 14,15,16,17,18,19].
Masculinization depends on the Sry (“sex-determining region Y”) genes on the TDF (testis-determining factor) locus on the Y chromosome [20,21,22,23,24,25]. Early in embryonic development, the gonads are undifferentiated and are identical in males and females, having bipotential precursor cells which can develop either into testis or ovaries. The differentiation of the bipotential gonad into a testes is determined by the sry genes on the Y chromosome and is controlled by a cascade of gene expression which is regulated by transcription factors. The differentiation of these precursor cells into testes is induced by the expression of the SRY gene in somatic cells that differentiate into Leydig (Androgen producing) and Sertoli (sperm producing) cells.
If there is no Y chromosome or if the SRY gene is missing, the bipotential precursor cells of the gonad develop into ovarian follicular cells and, under female-specific gene expression, oocytes develop. If there is a Y chromosome or if an X chromosome has SRY gene, testes develop. At the beginning of embryonic development, embryos of the two sexes differ only by their sex chromosomes, but once the Sertoli cells begin to secrete androgens, sexual differentiation begins. The Dmrt1 gene is essential for maintaining the differentiated testes and for preventing ovarian development in postnatal mouse testes [21, 26]. The Y chromosome may therefore act independently of sex hormones to regulate sex differences in growth and metabolism, cardiovascular diseases, immune system physiology, and autoimmune and infectious diseases [16, 27]. The testes-determining gene SRY is also expressed in the hypothalamus, midbrain, and cortex and masculinizes these neurons. SRY is particularly expressed in the Tyrosine hydroxylase (TH) containing dopaminergic neurons of the Substantia nigra pars compacta (SNpc) that project to the striatum and masculinizes these neurons which are involved in motor behavior [28]. Downregulation of SRY in these TH neurons in the substantia nigra (SN) results in deficits in DA and in sensori-motor function (as occurs in Parkinson's disease, which occurs more often in males than females) [28].
There is no single ovary-determining gene in females that is analogous to SRY in males, but there are a number of genes and transcription factors that activate ovarian development in the absence of SRY. Throughout the development of the ovary, the Foxl2 gene is required to suppress Dmrt1 expression and prevent the masculinization of granulosa and theca cells into testicular Sertoli and Leydig cells [21, 26]. The granulosa cells of the ovary produce the female sex steroid hormones, estrogen and progesterone, and the follicular cells produce the oocytes [20, 25, 29].
Although females have two X chromosomes, one is inactivated in each cell during development, so that females are mosaics, with some cells having a maternal X chromosome (Xm) and some cells having a paternal (Xp) chromosome [3]. Thus there is a sex difference in X chromosome "dosage": females have two X chromosomes and males only one [30]. There are three X chromosome effects that influence sexual differentiation: (1) The X chromosome that is inactivated can be from the mother (Xm) or from the father (Xp) resulting in "parental imprinting" or parent of origin effects as the active X chromosome expresses the trait of the parent from which it was derived ("you have your mother's eyes, but your father's nose”); (2) Some genes escape from X inactivation and are expressed on both X chromosomes in females; and (3) Some genes are “dosage dependent” and cells with two X chromosomes may express more of these genes than cells with one X chromosome [30]. Genes on the X chromosomes appear to influence sex differentiation of females, but the expression of genes on the X chromosomes is a complex phenomenon.
Genetic and Epigenetic Disorders of Sex Determination
A number of NDDs are due to abnormalities in sex chromosomes and sex determination [31] (Table 11.2). These disorders are the result of abnormalities in gene transcription during the differentiation of the bipotential gonad into testes or ovaries [32, 33]. In Turner's syndrome, a female has only one X chromosome (45X0) and is incompletely feminized, with gonadal dysgenesis, premature loss of oocytes, and infertility. In Klinefelter's syndrome, the most common disorder of male sex determination, a male has one or more extra X chromosomes (47XXY; 48XXXY) and is partially feminized, resulting in small testes, infertility, and the possibility of ambiguous external genitalia at birth [26, 34, 31]. Trisomy X (47XXX) is the most common female chromosomal abnormality and has little effect on sexual differentiation [35]. If the SRY gene is displaced from the Y to the X chromosome, then a person with a 46XXSRY phenotype is masculinized and develops male genitals. Because there is a "normal" male phenotype, this disorder is often not discovered until puberty is delayed or men are found to be infertile or develop gynecomastia. However, the testes may be small and there may be incomplete masculinization of the external genitals at birth [36]. Males with 47XYY syndrome have a normal male phenotype but may have reduced fertility [37]. In 48XXYY syndrome males have both an extra Y and an extra X chromosome, resulting in hypogonadism and reduced fertility [38]. In the majority of these sex chromosome disorders, there are neurobehavioral developmental disorders, which are described in the references cited.
The differentiation of the bipotential gonad into testes or ovaries requires epigenetic mechanisms that regulate the temporally organized sequence of gene expression for both sex determination and sexual differentiation [39]. DNA methylation is essential for X chromosome inactivation and for genomic imprinting and epigenitic dysfunction can disrupt these processes in developing females. Disorders of DNA methylation may also disrupt the ability of the SRY gene to masculinize males [40]. Likewise, disruption of histone methylation and noncoding RNA functions can disrupt sex determination [39]. Environmental stimuli, including nutrients and endocrine disruptors, can also disrupt sex determination and sexual differentiation [41].
The Neurobiology of X-Linked Intellectual Disabilities and Infectious Diseases
Over 140 genes on the X chromosome may contribute to X-linked intellectual disabilities [42] and other X-linked genes contribute to immune system function and susceptibility to infectious diseases [43]. Because males have only one X chromosome, many X-linked intellectual disorders affect males more than females; however, some of these, such as fragile X syndrome, affect both sexes. Others, such as Rett syndrome (RTT) and CDKL5 syndrome, occur almost exclusively in females [44, 45] but do occur in some males [46,47,48]. Sex hormones interact with genetic and epigenetic factors in determining sex differences in NDD and this interaction will be discussed in Section “Genetic and epigenetic factors in brain sexual differentiation”. Mutations in X-linked genes involve loss of neuronal function by altering dendritic spine size, shape, and density, resulting in the impairment of both excitatory and inhibitory neurotransmission [49]. The synaptic pathologies related to Fragile X syndrome are caused by mutations in the Fmr1 gene; RTT, caused by Mecp2 gene mutations; and "atypical Rett syndrome," caused by CDKL5 mutations [49]. X-linked NDD can also be caused by mutations in Rgo GTPase genes and genes coding for cell adhesion proteins, such as L1CAM and the Neuroligins, all of which affect synapse function [49].
Human females have a stronger innate and humoral immune response than males and are, therefore, less susceptible to many infectious diseases (bacterial, fungal, parasitic, and viral infections) but more prone to autoimmune disorders [43, 50, 51]. These sex differences in immune responses (Fig. 11.1) may be due to X chromosome-linked genes and to X chromosome inactivation as the noncoding micro RNAs on the X chromosome can influence the sex bias in disease frequency [43, 51]. As a result of sex differences in the immune system, there are also sex differences in responses to vaccines, with females showing not only greater antibody responses to vaccines than males but also more adverse side effects [52]. Because females with Turner's syndrome (45 X0) have only one X chromosome, their immune responses are impaired compared to 46XX females, while males with Klinefelter's syndrome (47XXY) have one X chromosome inactivated and they have a feminized immune response [43, 50].
Since the androgen receptor is also coded for by genes on the X chromosome, sex differences due to the actions of testosterone are regulated by genes on the X chromosome [43]. Since testosterone inhibits immune system activity by upregulating inflammatory cytokines, such as IL-10, and estrogen enhances immune system responses by upregulating pro-inflammatory cytokines, such as TNFa, the genes on the X chromosome modulate sex differences in susceptibility to infectious diseases [43, 50]. While some of the sex differences in disease susceptibility are only evident after puberty, sex differences in immune responses also occur in infancy and old age, suggesting that genes on the sex chromosomes and the sex hormones may have independent effects on sex differences in immune responses [43, 50, 51, 53].
Sexual Differentiation of the Brain
As discussed in Chap. 1, sexual differentiation occurs during three critical (sensitive) periods (Fig. 11.1): (1) a prenatal critical period during which androgens masculinize males; (2) a postnatal sensitive during which estrogens feminize females; and (3) a pubertal sensitive period during which secondary sex characteristics develop and sex differences in the brain and neuroendocrine system become activated [15, 54,55,56,57,58,59]. Sexual differentiation during these critical periods involves interactions between genes, sex hormones, the neuroimmune system, and environmental stimuli (Fig. 11.1). At puberty, the surge in gonadal hormones activates the cells that were sexually differentiated during the pre- and postnatal organizational periods. However, puberty is also a critical organizational period for sexual differentiation [60, 61]. The sexual differentiation of the brain during these critical periods determines the organization of sensory, motor, cognitive, and socio-sexual behavior throughout the lifespan [62,63,64,65].
There are androgen and estrogen receptors in the brain, each with different spatial distributions (Fig. 11.2). During the critical period of sexual differentiation, testosterone is aromatized to estradiol and binds to E2 receptors to masculinize the brain [55, 66, 67]. The aromatize enzyme is located primarily in those areas of the brain which regulate reproductive behaviors: the hypothalamus and amygdala; however, there are neurons containing aromatase in the hippocampus, cerebral cortex, cerebellum, and spinal cord. Aromatase has also been detected in radial glial cells and astrocytes [68]. Aromatase levels in the preoptic area and hypothalamus peak during the critical period of sexual differentiation by testosterone, but the timing of aromatase mRNA expression varies in different brain areas, suggesting a range of functions [67, 68].
The aromatization theory indicates that testosterone is aromatized to estrogen which masculinizes the male brain. But the female ovary produces estrogens, so why do not these estrogens masculinize the female? The answer is that alpha-fetoprotein (AFP), which is produced by the fetal liver, binds to circulating estrogens and prevents them from masculinizing and defeminizing females [66, 69]. Excessive estrogens during the prenatal critical period can masculinize the female fetus, producing a number of disorders of female sexual differentiation [55, 70]. While estrogen masculinizes the brains of rodents, androgens binding to androgen receptors appear to masculinize the brains of humans and other primates [71]. However, this is a controversial issue as there is a debate whether it is androgen or estrogen that masculinizes the brains of primates [72, 73]. AFP does, however, have a number of functions during development, including the regulation of growth, apoptosis, and regulation of the immune system [70]. While estrogens during the prenatal critical period of sexual differentiation will masculinize female rodents, there is a second postnatal critical period (Fig. 11.1), in which estrogens are necessary for feminization [55]. This critical period for estrogens to feminize female rodents appears to be from 15 to 25 days postnatal age. During the early postnatal period (PND 1–15) it appears that estrogens continue to masculinize the female brain but after day 15, they feminize the female brain [74].
Genetic and Epigenetic Factors in Brain Sexual Differentiation
Sex differences in the brain may be due to the expression of the SRY gene in the cortex, midbrain, hypothalamus, and SN [75]. Since SRY acts as a transcriptional activator and as an activator of epigenetic processes, such as DNA methylation, histone acetylation or methylation, and posttranscriptional regulation of noncoding RNA (ncRNA) or microRNA (mRNA), it can modulate the sexual differentiation of neurons and glial cells [22]. SRY gene expression can also modulate the actions of the enzymes TH and monoamine oxidase A (MAO-A) in catecholamine and dopaminergic pathways in the midbrain, resulting in sex differences in these neurotransmitter systems [75]. Sex differences in brain development are modulated by DNA methylation [76]. Masculinization of the brain requires androgens to suppress DNA methylation, while brain feminization is promoted by DNA methylation. Numerous environmental factors, including poor nutrition, drugs, and physical and mental stressors, can alter the epigenetic gene regulation of neural development, resulting in a number of different NDDs [77]. However, unlike gene mutations, which are permanent, epigenetic mechanisms are reversible; thus, NDDs that are caused by epigenetic mechanisms could also be “repaired” by epigenetic reversibility of the environmental stimuli that caused them in the first place: "epigenetic therapeutics": drugs, behavior therapy nutrition, or stress reduction ([77,78,79]).
Genes, Hormones, and Microglia Interact in the Sexual Differentiation of the Brain
Although the sexual differentiation of the brain is testosterone dependent [80], the sex chromosomes, transcription factors, and microglia are all involved in the sexual differentiation of the brain [16, 19]. Based on the four core genotypes model in which the effects of an XX versus XY genotype without gonadal hormones can be tested, it was found that genes on the Y chromosome coded for an increase in the number of dopaminergic (TH positive) cells in the mesencephalon on embryonic mice [81]. Gonadal steroid hormones activate their receptors in specific brain areas by binding to nuclear transcription factors to active gene transcription and protein synthesis, and the development of sexually dimorphic neural pathways (Fig. 11.2) is modulated by microglia as well as other chemical signals during critical periods [82]. It is hypothesized that microglial cells are sexually differentiated by gonadal steroids during the embryonic organizational period and that they are then involved in modulating the sexual differentiation of particular brain areas [83]. Microglia clear debris from the brain and regulate synaptic communication in adults, but in the developing brain they may eliminate redundant or apoptopic (dead) neurons, modulate synaptogenesis, and regulate the development of neural circuits (See Chap. 1).
Sexual Differentiation of Glial Cells: Astrocytes and Microglia
As noted in Chap. 1, glial cells play an important role in brain development and are intricately involved with synapses, forming a “Tripartite synapse” with the pre-and postsynaptic neurons [84, 85, 86]. Glial cells show sex differences in adults and this differentiation occurs during critical periods of development. However, glial cells also regulate the sexual differentiation of neurons; thus, glial cells are both the targets and promoters of sexual differentiation in the brain [87, 88]. Astrocytes and microglia (Fig. 11.1) are sexually differentiated [89, 90]. Microglia show sex differences in cell number, morphology, and function, which develop during critical organizational periods [83]. There are also sex differences in the number of astrocytes in the medial amygdala in mice and rats [91].
There are three stages of microglial cell development in the brain of rats: the early embryonic period (E10.5–14), the perinatal period (E14–P9), and adolescence (P28 and later) [92]. Humans have two embryonic phases of microglia development; one at four–five weeks into gestation and a second at 10–13 weeks of gestation [92]. There are age-related sex differences in microglia in the amygdala, hippocampus, and nucleus accumbens (NAc) in rats [92] (Fig. 11.1) and microglia are differentially expressed in the cerebral cortex, hippocampus, striatum, and cerebellum of male and female mice [92]. During the embryonic critical period for masculinization of the mPOA, males have twice as many microglia as females and a more activated morphological profile. During the first few days after birth in rats, males have more microglia than females in the sexually dimorphic medial preoptic area of the hypothalamus as well as the amygdala and hippocampus [90]. On the other hand, females have more activated microglia as juveniles and adults (P30–60). The sex differences in the development of microglia at different ages suggests that during the organizational period there might develop sex differences in the innate immune system which could result in lifelong sex differences in disease susceptibility [92].
There are three mechanisms through which microglia can be sexually differentiated: sex chromosomes, gonadal steroid hormones, and neural environment. Since all glial cells have male or female sex chromosomes, direct expression of the genes on these chromosomes may lead to sexual differentiation of the glial cells. Testosterone may masculinize glial cells during the prenatal critical period by aromatization to estrogen and sex differences in microglia are responsive to the neural environment in which they function [87, 92]. The sex differences in microglia differ in different brain regions; thus, there is not a unitary sex difference: The local activity of growth factors, cytokines, NT, NP, and hormones shapes the maturation of the microglia in each brain area. Sex differences in microglia formed during the prenatal organizational period may persist for a lifetime due to epigenetic programming. Histone acetylation or methylation or DNA methylation may be “imprinted” during the organizational period so that microglia retain the male or female phenotype for life [87] (Fig. 11.1). Finally, environmental stimuli, such as high fat diets, pollutants, stress, infection, or environmental toxins, may disrupt the sexual differentiation of glia and/or disrupt the role of microglia in sexual differentiation [87, 93].
Sex Differences in the Brain
Since every brain cell in males has an X and a Y chromosome and every brain cell in females has two X chromosomes, every brain cell shows a genetic sex difference, and since many brain cells have androgen and/or estrogen receptors, many neural circuits are sexually differentiated [94]. There are many types of sex differences in the brain. Some neurons only develop in one sex, while others are larger in one sex. Sex differences in the brain can be examined in terms of (1) neuroanatomy, (2) neural circuits, (3) neurochemistry, and (4) neuroendocrinology. This has led to the "mosaic hypothesis" which proposes that some brain areas are masculinized, while others are feminized [95]. Another way of looking at sex differences in the brain is to distinguish morphological differences in neuron size, shape, or number (sexual dimorphism) from biochemical, physiological or pharmacological sex differences in cell function (sexual diergism) as defined by Rhodes and Rubin [96]. It has been proposed that neuroinflammatory signals are the "primary drivers of the masculinization of specific brain regions" while steroid hormones modulate the neuroimmune signaling [16, 82]. Sexual dimorphism in neural and glial cells gives rise to neuromorphological cell phenotypes, while sexual diergism in neurochemistry and neurophysiology gives rise to neurochemical phenotypes (see [62]). Both sexual dimorphism and sexual diergism result in sex differences in cognition, emotion, and behavior.
Neuroanatomy
In the human brain, there are sex differences in total brain morphology, with males having larger volumes than females, as well as regional sex differences in gray matter volume and density [97]. Males also have larger amygdala and thalamus volumes than females as well as larger NAc, putamen, and hippocampus [98, 99]. There are sex differences in the size or volume of brain cells in the cortex and cerebellum of humans, as well as in subcortical structures: the thalamus, amygdala, hippocampus, hypothalamus, and many other areas (see [97,98,99,100,101]). However, the distributions of measures of brain parameters for males and females have significant overlap (Joel et al 2019; [99]). There are very few nuclei which have very large sex differences. These include the bed nucleus of the stria terminalis (BNST), the interstitial nucleus of the anterior hypothalamus (INAH1), which is also called the sexually dimorphic nucleus of the preoptic area, the INAH3, and the infundibular nucleus (Joel et al., 2019; [100]). The use of a deep learning technique found sex differences in whole brain measures as well as a number of specific brain areas in the cortex, thalamus, cerebellum, and limbic system of men and women [102]. However, some sex differences in neuroanatomy, particularly in the limbic system, may be influenced by social-emotional factors during development and thus environmental epigenetic stimuli may facilitate brain plasticity during development, resulting in significant individual differences in neuroanatomy within and between sexes [103]. Likewise, there are sex differences in the neuroanatomy in many areas of the rodent brain, including the cortex, hippocampus, olfactory bulb, amygdala, septum, thalamus, and hypothalamus [101, 104, 105].
Neural Circuits
As well as the size of particular brain regions, there are sex differences in the extent of dendritic arborization, the density and pattern of synaptic connections, the size, number, and phenotype of neurons in a particular region and glial cell morphology. All of these structural differences are believed to underlie adult sex differences in behavior. It is not possible to discuss all of the sexually dimorphic and sexually diergic areas of the brain, so I will focus on some of the sex differences in (1) the olfactory pathways, (2) the hypothalamus, (3) the hippocampus, (4) amygdala, and the (5) locus coeruleus (Fig. 11.4) [106,107,108,109,110].
-
(1)
The neurons of the olfactory bulb and the olfactory connections to the medial amygdala, BNST, mPOA, AVPV, and VMH which regulate socio-sexual behavior of mice are sexually differentiated by androgens during the prenatal organizational period (Fig. 11.3) [106,107,108,109,110].
-
(2)
Several hypothalamic nuclei show sexual differentiation during embryonic and pubertal development [100, 105] (Fig. 11.3). These include (1) the sexually dimorphic nucleus (SDN) of the medial preoptic area (mPOA) which is larger in males than females [111,112,113]. (2) The central region of the BNST is masculinized by androgens and is larger in males [114, 115], while the anterior BNST (the oval nucleus of the BNST) and the ventral BNST (vBNST) are feminized by estrogens and are larger in females than males [116, 117]. (3) The anteroventral periventricular nucleus of the preoptic region (AVPV) of the hypothalamus is larger and contains more neurons in females than in males [111, 118, 119]. (4) There are numerous pathways in the ventromedial nucleus of the hypothalamus (VMH), which are sexually dimorphic regulate sex differences in metabolism and energy expenditure as well as sexual behavior and aggression [120,121,122].
-
(3)
A number of nuclei in the hippocampus are sexually differentiated by androgens during the prenatal critical period [123], and there are sex differences in synapse formation and dendritic arborization of hippocampal neurons. Males show more CA1 pyramidal neuron dendritic arborizations than females, while females show more primary dendrites in the CA3 area [124, 125]. As in the hypothalamus, the sex differences in the CA1 area may be localized into male-specific and female-specific pathways, but these differences may be labile and depend on the activational effects of hormones at puberty and on epigenetic activation of gene expression in particular neurons [126, 127]. Bundy et al. [128] found over 60 genes that were differentially expressed in the hippocampus of male and female mice, suggesting that many sex differences have yet been described. The hippocampus functions in cognitive and emotional behavior [129, 130] and sex differences in cognitive function, depression, and NDDs involve the hippocampus [125, 127, 131].
-
(4)
The medial amygdala is responsive to changes in androgen levels in adulthood and shows morphological plasticity with circadian, annual, and socially modulated androgen levels [132]. Sex differences have been shown in the anatomy of the amygdala [97, 133, 134], with some nuclei being masculinized and some feminized. The medial amygdala is intricately associated with olfactory pathways (see Fig. 11.3) and olfactory stimuli from conspecifics (Pheromones) activate different sexually dimorphic neurons in the medial amygdala in males and females [106, 135].
-
(5)
The Locus coeruleus of females has a larger volume and a greater number of neurons than in males and it appears that the number of such cells is reduced by apoptosis postnatally in males, while estrogen modulates the survival of these neurons in females [136,137,138]. The locus coeruleus (LC) of females has more noradrenergic neurons than males and these have larger and more complex dendrites than those of the male LC [136].
Neurochemistry
As noted by Nieuwenhuys [139], the chemical signaling pathways of the brain transect its neuroanatomical regions. Many neurons have steroid hormone receptors and these steroid hormone target neurons are susceptible to sexual differentiation (Figs. 11.2). Thus, although the neuroanatomical regions of the brain, such as the medial preoptic area, ventral hypothalamus, hippocampus, and amygdala, can be defined morphologically, these anatomical regions may contain a plethora of neurochemically differentiated neurons which use different neurochemicals and have been sexually differentiated by androgens or estrogens during critical periods [122, 140,141,142]. There are sex differences in a number of neurochemical systems in the brain. These examples of sexual diergism mean that there can be functional differences in chemical signaling and intracellular communication that are not measurable in terms of brain morphology [96]. These include the locus coeruleus noradrenergic system [136]; the cholinergic system [143, 144]; and sex differences in GABA release in the neurons of the BNST [145, 146]. There are also sex differences in neuropeptide signaling systems, including enkephalin, CCK, and beta endorphin (See [147]).
There are many different patterns of sex differences in neural signaling pathways.
(1) The neurons in one sex can be eliminated by apoptosis, while those in the other sex are rescued by neurohormone actions. Such apoptotic processes may involve steroid hormone activation of glial cells, immune cells, and epigenetic activation of genes regulating either cell death or cell survival pathways. (2) There is a larger number of neurons in a particular neuroanatomical area in one sex than in the other. (3) There are more dendritic spines and/or synapses on neurons in one sex than in the other. (4) There are sex differences in the pattern of neurochemical signals in the neurons of each sex. (5) There is differential activation of intracellular biochemical pathways in each sex resulting in differences in gene expression. (6) There are sex differences in epigenetic responses of neurons to the same neurochemical stimulation resulting in sex differences in gene expression. (7) The responses of neurons to sex hormones is plastic, depending on the environment so that the same neuron may under some circumstances express a female pattern and under other circumstances express a male pattern. (8) There are sex differences in the actions of glial cells. (9) There are sex differences in the actions of immune-related cells and the release of cytokines. The end result is that a cascade of neurochemical signals results in a sexually dimorphic pattern of gene expression in a cell which regulates sex differences in physiology, metabolism, and behavior (Fig. 11.4) [140, 142, 148].
Summary: Sex Differences in Brain Structure, Function, and Neurochemical Pathways
The study of sex differences in the brain and their relationship to NDDs is undergoing a paradigm shift based on the availability of more and more sensitive molecular and genetic technologies. Whereas the initial studies focused on morphological differences in particular neuroanatomical regions, the newer studies focus on gene expression and molecular differences in specific neurons. For example, Labonte et al. [149] identified sex-specific gene expression patterns in six brain regions associated with sex differences in major depressive disorders (MDD) in humans [the ventromedial prefrontal cortex (vmPFC), orbitofrontal cortex, dorsolateral PFC, anterior insula (aINS), NAc, and ventral subiculum (vSUB)]. This seems to be the future of studies on sex differences in the brain underlying neurodevelopmental and neurodegenerative disorders. The key breakthrough, however, will involve understanding how sex differences in gene expression and molecular biology lead to sex differences in neurochemical communication and synaptic function, because synaptic damage seems to underlie all neurodevelopmental and neurodegenerative disorders [150,151,152]. Synaptic organization underlies neural development during critical periods [153] and both pre- and postsynaptic molecules are involved in NDDs [152, 154,155,156,157]. Sex differences have been found in almost all neurochemical systems, including those underlying neurodevelopmental and neurodegenerative disorders and sex differences in these neurotransmitter and neuropeptide pathways occur throughout the brain [147, 158, 159]. Sex differences at synapses (Fig. 11.2) can occur in the release of neurotransmitters from pre-synaptic nerve terminals or in their receptors at pre- and postsynaptic nerve terminals [160], or in the excitatory/inhibitory synapse ratio [161, 162]. As noted below, sex differences may also occur in the contribution of glial cells to “tripartite synapses,” the neuro-immune system or even the communications between the gut microbiome and the brain [163].
The Role of Glial Cells in the Sexual Differentiation of the Brain
Astrocytes are involved in synapse development and function and microglia regulate neuron cell number during development and facilitate cell proliferation and differentiation and may play a role in the sexual differentiation of brain areas by regulating apoptosis (See Chap. 1). Microglia also regulate axon outgrowth and synaptogenesis; modulating activity-dependent synapse formation by eliminating weak synapses and promoting the growth of new ones [88]. Microglia play different roles at different times during development, but at each developmental period, they are involved in the sexual differentiation of the nervous system (Fig. 11.5). During embryonic development, microglia have organizational effects through the promotion of neural proliferation and cell survival by secreting cytokines which facilitate neural development and neural circuit development and abnormalities during this period have lifelong effects. During this embryonic critical period, testosterone masculinizes the POA by stimulating microglia to facilitate the development of synaptic spines [164]. In females, microglia appear to function postnatally to feminize the brain by facilitating synapse development during the first few postnatal weeks [165]. Later microglia prune superfluous cells by inducing apoptosis and facilitate axonal outgrowth and synaptic connectivity by promoting synaptogenesis and pruning excess synapses [87]. In adulthood, microglia facilitate experience-dependent synaptic remodeling by regulating the interface between environmental (epigenetic) stimuli and synaptic changes in neural circuits [88]. These effects are more like activational effects, but they are susceptible to disruption by environmental stressors or endocrine disruptors.
The Role of Glial Cells in Sex Differences in NDD
Given the complex interactions between astrocytes, microglia, and neurons in the sexual differentiation of the brain, it is no surprise that glial cells may be involved in the sex differences in NDDs [166, 167]. Astrocytes are essential for synapse formation and synaptic function and sex differences in gliotransmission may be involved in the sex differences found in NDD [84, 156]. Thus, the role of astrocytes in sex differences in NDD may be in their role in the tripartite synapse and the modulation of synaptic activity, possibly by regulating the E/I ration of synapses [168]. Neuroinflammation is an important component of a number of neurodevelopmental and neurodegenerative diseases and microglia may mediate sex differences in NDD by regulating neuroimmune responses during early development as well as in adulthood and aging [11, 169]. This could occur through sex differences in the elimination of synapses by microglia during synaptic pruning, or through sex differences in the neuroimmune responses of microglia to external (environmental) stimuli (Fig. 11.5). Since microglia are involved in sexual differentiation, they may be involved in X-linked NDDs. Finally, the sex hormones, estrogen and testosterone, may have differential effects on microglia [170], being neuroprotective or neurotoxic, depending on the neural environment. For example, chronic stress has differential effects on astrocytes and microglia in males and females and this difference may be mediated by the sex hormones [171]. Likewise, during a state of low oxidative stress, sex hormones may be neuroprotective, but during high oxidative stress they may be neurotoxic [172]. Nevertheless, it is becoming increasingly clear that microglia are involved in the sexual differentiation of the brain, in sex differences in neuroimmune activation and in the development of sex differences in neural dysfunction in infancy, adulthood, and aging [169, 173].
Gut Microflora, the Immune System, Glial Cells, and Sex Differences in NDD
As if things were not too complex already, the role of gut bacteria, the microbiome, adds yet another factor in the causal chain of sex differences in NDD. The microbiome and microglia communicate with one another through a number of chemical signals, including neurotransmitters (serotonin, noradrenaline, or dopamine), short-chain fatty acids (such as propionic acid (PPA), acetic acid (AA), and butyric acid (BA)), cytokines, and microbial-associated molecules (such as bacterial lipoproteins, double stranded RNA and lipopolysaccharides) [174]. Secondly, the microbiome may act as an epigenetic regulator of microglial phenotypes, thus influence microglial function during development [175]. Thirdly, through their communication with the microglia and other immune functions, the microbiome can influence the development of NDD [176]. Finally, there are sex differences in the gut–brain axis [177], which can contribute to the sex differences in the onset of NDD [178]. A microbial imbalance in the gastrointestinal tract (gut dysbiosis) seems to be one of the major causes of sex differences in NDD. It has been proposed that sex differences in gut microflora may underlie sex differences in metabolic disorders [179]; major depressive disorder [180]; autism spectrum disorder [178]; and other neuropsychiatric disorders (see [181]). The microbiome–immune–microglia interactions can be activated by environmental stressors (early life adversity) and affect the functioning of the autonomic nervous system in a sex-dependent manner [182], resulting in sex differences in stress-related behavior and sympathetic nervous system activation, which underlies neurovascular disorders, such as hypertension [183]. The gut microbiome may modulate sex differences in neural development through communication with the immune system via microglia [169, 174, 184] and led to sex differences in neural development and in a wide range of NDD and other neural disorders [177]. Figure 11.6 presents an overview of the complex interactions between the gut microflora, immune system, neuroendocrine system, genes, and environmental stimulation in the sexual differentiation of the CNS.
Sexual Differentiation of the Hypothalamic-Pituitary (Neuroendocrine) System
The pituitary gland has two distinct parts: the adenohypophysis (anterior pituitary) and the neurohypophysis (posterior pituitary), each of which is connected to the hypothalamus [185, 186, 187]. The posterior pituitary (neurohypophysis) is formed from neural tissue, while the anterior pituitary (adenohypophysis) is a true endocrine gland. During development the two parts of the pituitary gland become intertwined through a complex series of genetic, epigenetic, and hormonal interactions [185, 188,189,190,191,192,193,194]. The hypothalamic-pituitary system is sexually differentiated in a number of complex ways. The neurohypophyseal system consists of the neuroendocrine cells of the Supraoptic nucleus (SON) and the Paraventricular nucleus (PVN) of the hypothalamus which synthesize the neurohormones oxytocin and vasopressin, and which send their axons down the hypophyseal stalk (Infundibulum) to the Pars nervosa or posterior pituitary gland where these hormones are released into the bloodstream [195, 186]. In addition to their hormonal function in the bloodstream, oxytocin and vasopressin are also released into neural pathways in the brain where they act as neuromodulators [196,197,198].
The adenohypophysis (anterior pituitary) contains five types of endocrine cells which secrete growth hormone, prolactin, LH and FSH, ACTH, and TRH as well as cells in the pars intermedia which secrete MSH [186]. Synthesis and secretion of the hormones of the adenohypophysis is regulated by the hypothalamic hypophyseal hormones, which are secreted from the parvocellular neurons of the PVN, ventromedial nucleus, and other nuclei of the hypothalamus and released into the bloodstream in the median eminence of the hypothalamus, from which they travel down the hypophyseal portal veins of the pars tuberalis in the pituitary stalk to the adenohypophysis. As with the neurohypophyseal hormones, the hormones of the adenohypophysis also act as neuromodulators in the brain
Neurohypophyseal Hormones and Sex Differences in NDD
Both vasopressin and oxytocin may mediate sex differences in NDD involving social behavior and anxiety-related behavior. The lateral septum AVP system is involved in sex differences in social recognition, social play, and anxiety-related behavior in rats, while the mPFC-OXY system is involved in socio-sexual motivation in female mice and anxiety-related behavior in mice [199]. It appears that OXY and AVP have some neuromodulatory effects on sex differences in NDD, but the effects are quite complex and their effect may be to shift the excitatory/inhibitory NT balance in subtle ways to influence both vulnerability and resilience to the development of NDD. Oxytocin and vasopressin systems have been implicated in Autism spectrum disorder, Prader-Willi syndrome, Williams syndrome, and Fragile X syndrome; however, the exact role of these neuromodulators in these disorders is unclear [200]. Given the importance of oxytocin in social and sexual behavior, there has been considerable attention to its role in Autism Spectrum Disorder [201]. The amount of oxytocin released, the number of oxytocin receptors, and the function of glycoprotein CD38, which is present on the surface of many immune cells (including CD4+, CD8+, B lymphocytes and natural killer cells) and also functions in cell adhesion, signal transduction, and calcium signaling, have all been implicated in ASD. However, the use of oxytocin analogues to treat ASD has met with little success [202, 203]. On the other hand, the social behavior and oxytocin abnormalities in ASD may be the result of dysfunctions in synaptic proteins, such as Neuroligan3 (NLGN3 gene) [204], a sex-linked gene found in the X chromosome [205]. In addition, genetic polymorphism and epigenetic modulation of oxytocin receptors have been implicated in ASD [206,207,208]
Adenohypophyseal Hormones, Sex Differences, and NDD
A complex spatio-temporal sequence of neurochemical and genetic events are involved in the sexual differentiation of the neuroendocrine hypothalamus during the fetal organizational period [209, 210]. The GnRH neurons are born in the olfactory placode and must migrate to the preoptic area of the hypothalamus. This is under the control of a number of genes, growth factors, cell adhesion molecules, and other chemical signals. Once the hypothalamic GnRH neurons develop, they begin to secrete GnRH which activates the pituitary and gonads. GnRH release is pulsatile and the “pulse generator” differs in males and females [211]. In males, androgens from the testes provide negative feedback, resulting in small regular pulses of GnRH. In females on the other hand, estrogen provides positive feedback, resulting in surges of GnRH secretion once every reproductive cycle (estrus cycle in rats, menstrual cycle in humans). However, the sex difference in the HPG feedback system is not regulated directly by the GnRH neurons themselves, which are not sexually dimorphic, but indirectly by a complex system of neurotransmitters and neuropeptides [212, 213], of which the kisspeptin neurons are the most important. The kisspeptin neurons are located in the MPOA/AVPV and in the Arcuate nucleus (ARC) and are sexually differentiated by gonadal steroids during prenatal critical periods [214]. Prenatal androgens promote the development of kisspeptin neurons in the ARC but not in the AVPV in males, while postnatal estrogen facilitates kisspeptin neuron development in the AVPV in females [214].
As well as kisspeptin, other neuropeptides and neurotransmitters are involved in the regulation of GnRH secretion. These include the neurotransmitters Glutamate, GABA, dopamine and noradrenaline, and the neuropeptides leptin, NPY, VIP, neurokinin B, and dynorphin as well as GnRI, gonadotropin inhibitory hormone [186, 210, 212, 215]. In mice, AVP and VIP stimulate kisspeptin neurons in the ARC more in females than in males, but Neurokinin B stimulates kisspeptin release equally in males and females [216]. The ability of neurotransmitters and neuropeptides to regulate GnRH secretion means that any epigenetic (environmental) factors that alter these neurochemical signaling pathways can affect the kisspeptin-GnRH release [212], thus providing a neural pathway for endocrine disruptors of many types to influence the hypothalamic-pituitary hormone systems. As if all these were not enough, the glucocorticoid hormones of the HPA system and the thyroid hormones of the HPT system also modulate GnRH release in a sex-specific manner through their effects on Kisspeptin, GnRH, and GnRI [212, 215].
HPG System
Failure of the HPG system to develop normally affects sexual differentiation, puberty, physical development, and reproduction. Mutations of kisspeptin or the KISS1R lead to disorders associated with pubertal development, such as precocious puberty and idiopathic hypogonadotropic hypogonadism. Failure of the GnRH neurons to develop normally can result in hypogonadotropic hypogonadism or in Kallmann syndrome or hypogonadotropic hypogonadism with anosmia (Table 11.2). In this case the GnRH neurons fail to migrate from their origin on the olfactory bulb to the hypothalamus and the olfactory neurons also fail to develop [217]. In this condition, there is no GnRH secretion, so puberty is delayed, and people are infertile. It is treated with gonadal hormone replacement therapy [218]. Males with GnRH dysfunction who have hypogonadotropic hypogonadism have abnormal kisspeptin – Kiss-R1 receptor development [219]. On the other hand, early activation of the Kisspeptin-GnRh system can result in precocious puberty in both girls (under age 8) and boys (under age 9) [217].
HPA System
The general consensus [220] is that females are more vulnerable to the long-term effects of early life stressors than males. Sex differences in the HPA system are most evident in responses to stress, which is associated with several psychiatric disorders that occur more frequently in women than men, including panic attacks, anxiety disorders, posttraumatic stress disorder (PTSD), and depression [221]. The stress response involves the activation of the HPA system and for some disorders, such as depression, women seem to have a stronger HPA activation than males; however, the evidence is controversial and sex differences in the HPA response to stress may differ between rodent models and humans [222]. Studies in rodent models indicate that females have a greater HPA response to stress than males, with a greater release of CRF, ACTH, and corticosterone [221, 223, 224]; however, in humans the sex difference in the cortisol response to stress depends upon the stressor [225]. After an extensive review of the literature, [220], concluded that there was evidence of increased HPA axis reactivity to stressors in human females compared with males, but this depends on a number of developmental and environmental factors and on the nature of the stressors. The HPA system in human males is activated more by cognitive and verbal stressors, while the HPA system of females is activated more by social stressors [225]. In addition, females have a greater HPA response in depression than males. Thus, it is clear that sex differences in the HPA system and the response to stress are very complicated.
Two results of the increased sensitivity of girls to HPA axis activation are the stress-related inhibition of puberty and the increase in major depressive disorder in females [226]. These sex differences in stress-related disorders may involve sex differences in the functions of the hypothalamic CRH which acts as a neuropeptide through its receptors in the brain, as well as a hormone acting at the adenohypophysis [222, 227, 228]. Sex differences in the HPA response to stress and the development of emotional disorders may be the result of early life stressors which affect the “developmental programming” of the HPA axis during critical periods of development [229, 230]. Early life stressors of many types (maternal stress, maternal deprivation, maternal nutrition, social stress, environmental stressors, inflammation) can act as epigenetic factors to shape sex differences in HPA responses to stress [228]. These epigenetic effects can occur through the neural pathways or through the involvement of the immune system and glial cells, such as astrocytes which modulate the development of the HPG neuroendocrine system [231,232,233]. Early life stress can alter the development of serotonin receptors (Htr2a and Htr1a) in the amygdala and the effects of stress on these receptors differs in male and female rats [234]. Early life stress increases the number of presynaptic Htr1a receptors and decreases the number of postsynaptic Htr2a receptors in females, but has little effect on males, thus indicating an epigenetic mechanism for the sexually dimorphic effects of early life stress on anxiety-related behavior, at least in rodents in this study. Sex differences in the effects of prenatal stress on the HPA system may be the result of sex differences in the responses of DNA methylation to early life stressors. In rats, for example, chronic restraint stress of pregnant females results in sexually dimorphic differences in the HPA axis [235], and in DNA methylation in the GR gene, resulting in sex differences in stress-related behaviors in adulthood [236]. Early life stressors induce sex-specific developmental changes in the neural connections between the PFC, amygdala, and hippocampus in rodents [237] and these connections may mediate sex differences in behavioral and HPA responses to stressors. Such epigenetic changes in neural pathways following early life stressors during development may be the cause of sex differences in major depression and other emotional disorders related to the HPA axis [238].
The HPT System
Congenital hypothyroidism is the most common endocrine disorder in newborn children and is the leading cause of preventable mental retardation [239]. Hypothyroidism (congenital, autoimmune) is sexually dimorphic [240, 241] with three times as many girls affected as boys (3:1 sex ratio) [242]. Females are also more prone than males to develop autoimmune thyroid disorders during puberty [240, 243] and since these disorders are caused by anti-thyroid antibodies produced by immune system, there is a neuro-endocrine-immune interaction in the sex differences in the development of thyroid disorders [244]. There are three other aspects of sex differences in HPT system that are related to NDD disorders: (1) metabolism and the growth spurt during puberty and obesity, (2) the sex difference in depression, and (3) epigenetic effects from environmental pollutants.
The HPT system is essential for thermoregulation and regulates energy balance by controlling energy expenditure, heat production, and metabolism [245]. Hypothyroidism results in lowered metabolic rate and hypothermia as well as delayed physical and mental growth. Since thyroid hormones stimulate bone growth and maturation, hypothyroidism is also associated with short stature. Thyroid hormones play an important role in the pubertal growth spurt and sex differences in body weight [246]. At puberty there is a surge in thyroid gland growth in both males and females, and after menarche, females have larger thyroid glands than males [246]. While GH and IGF1 may drive the increase in thyroid hormone growth at puberty, the sex difference may be the result of estrogen acting on the thyroid gland [246, 247]. Females are diagnosed with thyroid disorders, both hypo- and hyperthyroidism and are more likely to have thyroid autoimmune disorders than males [243, 248]. Sex differences in body weight control involve the regulation of energy homeostasis by the HPT system [249] and obesity related to hypothyroidism and autoimmune disorders is more common in women than men (see [250]). Sex differences in body fat distribution are related to sex differences in levels of circulating leptin and other adipokines [251]. Leptin levels rise at puberty and may be responsible for sex differences in fat mass after puberty: Girls gained more fat mass than boys, whereas boys gained more fat-free mass [252]. Leptin and other adipokines stimulate the immune system and since females have higher levels of leptin than males, this may be one underlying cause of sex differences in autoimmunity in general and in thyroid autoimmune disorders in particular [244]. Thus, the sex differences in body composition that occur during puberty reflect differential activity of the HPG system, the HPT system as well as leptin and other adipokines.
In addition to cognitive impairment, hypothyroidism may result in anxiety, depression or bipolar disorder, restlessness, psychomotor retardation, decreased appetite, fatigue, lethargy, and impaired concentration [248]. Women have a higher frequency of mood disorders than men, including unipolar depression and bipolar disorder which may be related to thyroid dysfunction [248]. Among patients hospitalized for depressive disorder and other neuropsychiatric disorders, females are more likely than males to have hypothyroidism [253, 254]. Low levels of TSH during development have also been associated with higher levels of ADHD in girls, but not boys [255].
Environmental toxins which disrupt the development of the HPT system (Thyroid-disrupting chemicals) have widespread effects on brain development [256]. Many of the same chemicals that disrupt the HPT system also disrupt the HPG system and thus may result in sexually dimorphic abnormalities in neural development [256, 257]. There are many endocrine-disrupting chemicals, and Bisphenol A (BPA) can be used as an example of a chemical which disrupts multiple neuroendocrine systems, including the HPT and HPG systems [258]. BPA is both an estrogen disruptor and a thyroid hormone disruptor, as it can interact with ER, AR, and thyroid hormone receptors (TRs) as well as other nuclear hormone receptors [259]. BPA inhibits thyroid hormone secretion and blocks TRs while stimulating estrogen receptors. It has been implicated in the increase in ADHD and related behavioral deficits in boys and in a reduction in cognitive function, but it also affects the immune system, insulin, and glucose metabolism and adipose tissue [256, 258, 260, 261]. There are sex-specific effects of prenatal BPA on NDD, suggesting that the interaction of the endocrine-disrupting effects of BPA on the sex hormones and thyroid hormones results in different NDD in boys and girls [262, 263]. Endocrine disruptors, such as BPA alter DNA methylation, by modulating the DNA methyltransferase enzymes (DNMT1 and DNMT3A) in estrogen receptors in the prefrontal cortex and hypothalamus differentially in males and females [264]. By altering DNA methylation and histone acetylation, BPA can cause widespread disruption of reproductive development, particularly in males [265]. Likewise BPA disrupts DNA methylation and histone modifications on androgen receptors and other hormone receptors [266]. Finally, early life anesthesia can result in neurodevelopmental abnormalities which differ between males and females [267]. General anesthetics can cause neural death (apoptosis) and thus act as neurotoxins during early brain development. Since anesthetics target GABA and NMDA receptors, they affect the development of the cortex, hippocampus, and hypothalamus through altering DNA methylation and histone proteins [267]. General anesthetics may also act as endocrine disruptors to alter the development of the HPT and immune systems [268].
GH and Prolactin
Short stature has been associated with a number of NDD, and this may be related to abnormalities in the HPT or GH/IGF1 systems [269]. The GH/IGF1 system has significant effects on brain development and synaptic function and abnormalities in the development of this system may underlie the development of certain NDD, such as Autism and RTT [270,271,272]. Abnormal synapse formation in Autism may be related to abnormalities in IGF1 levels, in the hippocampus and cerebellum [271]. The fact that the GH/IGF1 system is sexually dimorphic with increased activity in males, suggests that a dysfunction in this system during development may underlie the preponderance of males in autism and related NDD. There have been attempts to correlate elevated prolactin levels with the onset of psychoses in men and women [273], but although women had higher PRL levels than men, the results showed no relationship between prolactin levels and sex differences in psychoses. On the other hand, Labad [274] proposed that sex differences in the HPA system and PRL response to stressors may underlie the onset of schizophrenia.
Summary and a Caveat
Section “Puberty: The Organization of the Adult Brain and the Integration of Sex Differences in the Neuroendocrine, Neuroimmune, and Energy Homeostasis Systems” examines sex differences in the hypothalamic-pituitary hormone systems and suggested ways in which these could underlie sex differences in NDD. However, there is a significant difficulty in the study of sex differences in the neuroendocrine system underlying NDD in that everything depends on everything else, and the causal chain is a circle. For example, the HPG system is sexually dimorphic and sex hormones masculinize or feminize certain brain regions, leading to sex differences in the hypothalamic-pituitary release of hormones and then these hormones bind to their receptors in the brain, in a sexually dimorphic manner. So what came first: the sexual differentiation of neurons causing sexually different hypothalamic-pituitary hormone release OR the sexually different hormone release causing sex differences in neural development? One might argue that both are true at different developmental periods. During the perinatal organizational phase the gonadal hormones cause sexual differentiation of brain areas and then during the pubertal-adult activational phase, the sexually differentiated brain areas cause sex differences in hormone secretion. However, brain damage – abnormal neurogenesis and synaptogenesis – may cause both NDD and neurohormone abnormalities. The development of the brain and the neuroendocrine system, not to mention the neuroimmune system, are intricately linked and almost impossible to dissociate.
Puberty: The Organization of the Adult Brain and the Integration of Sex Differences in the Neuroendocrine, Neuroimmune, and Energy Homeostasis Systems
Puberty defines the border between childhood and adulthood. It involves the maturation of sex differences in the brain and the initiation of reproductive function. Puberty is both a period of activation of the sexually dimorphic neural pathways that were organized during the perinatal critical period and also a period of the adult organization of the sexually dimorphic neuroendocrine pathways. During puberty there is the maturation of the gonads, the development of secondary sexual characteristics, accelerated growth, changes in brain and behavior, and the attainment of reproductive fertility [61, 275, 276]. Puberty involves sex differences in gene expression underlying the reorganization and activation of many neurochemical systems, including the HPG, HPA, HPT, GH/IGF1, and leptin-related metabolic systems. Puberty also involves the sexual differentiation of the neuroimmune system. Because puberty is a critical period for the development of adult sex differences, the neuroendocrine changes during this time are susceptible to alteration by endocrine disruptors and other epigenetic mechanisms that can result in puberty-related NDD, including disorders of metabolism; early (precocious) of delayed puberty; disorders of sexual differentiation; psychiatric disorders; and disorders of gender identity and role.
Puberty-Related Neural and Neuroendocrine Reorganization
The primary activator of puberty is the change in negative feedback sensitivity of the HPG system which allows the increased release of GnRH, LH, and FSH, stimulating and increased release of gonadal hormones. This is regulated by leptin and kisspeptin [277]. The kisspeptin neurons in the ARC are “masculinized” by androgens (or high levels of estrogens via the aromatization of androgens during critical period of prenatal development) and regulate to pulsatile release of GnRH in males [214, 278]. At puberty, there is a critical period of sexual differentiation of neural development which leads to sex differences in cognition, behavior, emotionality, social behavior, and the onset of adolescent NDD [60, 279,280,281,282]. This involves the reorganization of a number or neural circuits in the hypothalamus, hippocampus, amygdala, and cortex [59, 60, 283, 284]. Sex differences in this “brain remodeling” involve (1) masculinization of the brain by androgens and an increase in neurogenesis in the sexually dimorphic neurons of the stria terminalis and mPOA-SDN of the hypothalamus which is not shown in females [57, 285], and (2) feminization of the locus coeruleus and the hypothalamic neurons that control the LH surge during ovulation [138, 286]. The medial posterior region of the BNST and the LC thus show opposite patterns of sexual dimorphism. The BNST in males is greater in volume and number of neurons than in females (male > female), while in the LC, the opposite is true (female > male) [287].
After puberty, there is a decrease in the number of neurons, dendrites and synapses in the prefrontal cortex while myelination in the white matter increases, and these changes are more marked in female rats than males [279]. A detailed description of the organization of sex differences in the brain at puberty is given by Peper et al. [288]. Ovarian hormones shape cell number and cell group volume female brains during puberty [59]. The increase in estrogen levels at puberty has been correlated with increases in gray matter in the left middle temporal gyrus and with decreases in gray matter in the superior- and inferior prefrontal, orbitofrontal, parietal, as well as temporal cortices. It is noteworthy that numerous changes in gray and white matter in the cortex were correlated with changes in levels of estrogen throughout the lifespans of human females [289]
Sex Differences in Microglia at Puberty
Glial cells play an important role in the sexual differentiation of the brain during the perinatal organizational period and a sex-specific role in the reorganization of the brain during puberty [290]. In adulthood, male microglia have an enlarged soma and have more pro-inflammatory responses than female microglia, while female microglia have a higher phagocytic capacity and higher capacity than male microglia for cell repair and inflammatory control (Fig. 11.7). These sex differences in microglia at puberty may influence the sex differences in the lifespan development of neurodegenerative diseases during later adulthood as well as NDDs [11]. Thus, some of the neuroprotective effects of estrogen may involve female microglia. For example, in mice, males show a greater inflammatory response than females to brain injury, while microglia from adult females reduce the damage caused by cerebral ischemia [291]. Microglia have been found to shape sex differences in dopamine pathways at puberty and thus influence sex differences in reward pathways. Microglia and immune-mediated phagocytic activity reduce the number of D1 receptors in the NAc of male but not female rats at puberty [292]. Interactions between glial cells, gliotransmitters, and neurons and neurotransmitters may be essential for the neuroendocrine changes in the hypothalamic-pituitary system at puberty, regulating both the HPT and HPG systems and modulating both metabolism and reproduction [293].
Sex Differences in Gene Expression at Puberty: Epigenetic Effects of Gonadal Hormones
The surges in gonadal hormones during the perinatal and pubertal critical periods are responsible for activating genes that regulate the sex differences in neuroendocrine and neurophysiological activity. In this way, the gonadal hormones act as epigenetic signals to regulate gene expression and this epigenetic modulation of gene expression can be permanent or transitory and can fluctuate across the estrus/menstrual cycle in females [294, 295]. Thus, sex differences in neural activity as the result of gene activation by gonadal hormones can fluctuate over time. This may be one of the many reasons why there is so much variability in measures of sex differences in neuron structure and function: as gonadal hormone levels fluctuate, so does gene expression and neural activity.
Sex differences in gene expression occur during specific critical periods and may be related to sex differences in neuropsychiatric disorders [296]. While DNA methylation at some sites showed sex differences in expression during the critical organizational period, others, which occurred during the perinatal organizational period, were not evident until after puberty [297]. Two genes were of particular interest for their consistent sex-specific expression at different ages: GPR37 (G protein-coupled receptor associated with Parkinson’s disease) in females and APLNR (the APELIN G protein-coupled receptor associated with control of the cardiovascular system) in males. Sexually dimorphic genes involved in synapse formation are also expressed at puberty. Finally, a number of sex-biased genes were shown to be related to NDD. In males these included genes related to autism, bipolar disorder, schizophrenia, Alzheimer’s disease, and Parkinson’s disease. Female-biased genes were related to OCD, schizophrenia, epilepsy, and AD. Finally, there are sex differences in the activation of gene expression in the PFC, NAc, and VTA of mice in response to stress and cocaine treatment [298]. This indicates a sex differences in gene expression in reward pathways (see below).
Summary
Puberty is both a time when the sex differences in the brain are activated with the rise in gonadal hormones and also a time when a second phase of brain reorganization occurs. While both of these changes depend on gonadal hormones, they involve a number of neurotransmitters and neuropeptides, along with the gonadal steroid hormones, all of which act to regulate gene expression and neuroendocrine development via epigenetic mechanisms of DNA methylation and histone modifications [297]. It is clear that the changes in reproductive function that occur at puberty are accompanied by changes in metabolism, growth, and the functions of the HPA and HPT systems. Puberty is thus a period of neuroendocrine system-wide readjustment which shifts the body from childhood to adulthood. Endocrine disruptors seem to have a more potent effect on puberty in females than in males, but more research has been conducted on puberty in females than males. What is clear is that a wide range of changes in neurochemicals and their receptors occur in the brain at puberty. While kisspeptin seems to regulate the changes in the HPG system at puberty, there are also changes in reward pathways and stress pathways which appear to be sexually dimorphic. All of these changes can result in puberty-related NDDs.
Puberty-Related Neurodevelopmental Disorders
Puberty is associated with a collection of NDDs. These can be divided (arbitrarily) into disorders of puberty timing, eating disorders and addictions, neuropsychiatric disorders, and disorders of sexual development (DSD).
Disorders of Puberty Timing
The most outstanding physiological and physical changes at puberty concern the sexually dimorphic development of secondary sex characteristics. As noted in Table 11.2, there are a number of disorders of sexual differentiation that become obvious at puberty that are due to genetic disorders of sex determination or perinatal hormone disorders of sexual differentiation [299]. The disorders of puberty timing involve precocious puberty or delayed puberty [300, 301]. While these disorders have traditionally been thought of as disorders of the HPG system, it is now clear that disruption of the Kisspeptin system (the Kiss1 gene or the Kisspeptin receptor) is involved in both precocial and delayed puberty as it regulates the release of GnRH [217, 302, 303].
Precocious puberty can be caused by premature activation of the hypothalamic-pituitary gonadal axis (true precocious puberty); by increased estrogen or androgen secretion due to steroid-secreting tumors, or to external steroid hormones in food or vis endocrine-disrupting chemicals (precocious pseudopuberty or Gonadotropin-independent puberty); or to the secretion of gonadal steroids from the adrenal gland (congenital adrenal hyperplasia). The result is that a child goes through puberty at an early age (as young as seven years old in girls or nine years old in boys). Precocious puberty is a sexually dimorphic disorder, being five to ten times more common in girls than boys [300, 301]. Delayed puberty is caused by the failure of the HPG system to develop (hypogonadotropic hypogonadism). In delayed puberty, there is no development of the secondary sexual characteristics. All of the hormones of the HPG system are at low levels, females do not ovulate or show a menstrual cycle and sperm production does not occur in males. Delayed puberty is more common in boys than girls [300, 301, 304].
Sex Differences in the Activation of Reward Pathways at Puberty: Eating Disorders and Addictions
After puberty there are sex differences in addictive disorders, including eating disorders, drug addiction, and other addictions [305] which may be the result of sex differences in neural reward pathways [306].
Reward Pathways
The reward pathways in the brain involve dopamine and the opioids and sex differences in these pathways in the NAc and VTA and their pathways to the PFC and the amygdala may mediate sex differences in obesity and addictions [306,307,308]. Although both men and women show addictive behaviors, women become addicted faster than men, experience more difficulties getting rid of their addictions, and relapse more often than men, and this may be due to the interaction of estrogen and androgens with the dopaminergic and opioid reward pathways [306, 307]. Exactly how sex differences in these reward pathways manifest in addictions is unknown (See long discussion by [306]).
Eating Disorders and Obesity
Puberty is one of the most common risk periods for the development of eating disorders, primarily anorexia nervosa and bulimia nervosa, which are more common in girls than boys [309, 310]. In girls the mean age for the onset of eating disorders is between 15 and 19 years of age, but for boys, there are fewer studies and the relationship with puberty is mixed (see [310]). It is possible that perinatal androgens which masculinize the brain reduce the likelihood of the development of eating disorders at puberty in males [309]. There are two ways of looking at sex differences in eating disorders and obesity related to puberty: (1) the close ties between metabolism and body weight with puberty and reproduction in females and (2) the general issue of eating as an addiction related to brain reward circuits. As discussed above, the timing of puberty and the initiation of reproduction in females is closely tied to metabolism and body weight. The development of female reproductive behavior at puberty in rats requires estrogen [74]. The rise in estrogen levels at puberty activates neural reorganization; the female brain is “shaped” by a cascade of hormones and neuropeptides that regulate metabolism and reproduction [289, 311, 312]. The key is the maturation and “rewiring” of hypothalamic neural circuits during puberty. Metabolic signals involving leptin, ghrelin, and insulin regulate the activity of kisspeptin and other neuropeptides regulating the hypothalamic control on GnRH. Thus, any disruption of the metabolic reproductive axis may result in eating disorders [311]. In boys, metabolism and the timing of puberty are less closely intertwined and so eating disorders may be independent of puberty in males.
On the other hand, the conception of eating disorders as addictions focuses on the role of reward circuits in the brain [306, 308, 313]. From this point of view, eating disorders are the result of disrupted dopamine and opioid systems in sexually dimorphic areas of the brain. Because so many components of the reproductive, feeding, and reward systems in the brain are activated at puberty, it is difficult to determine what exactly the term “sex difference” means. It can relate to the sex chromosomes, perinatal organizational period of gonadal sex differentiation, or to the many areas of the brain and neural pathways that are sexually dimorphic (See [314]). In addition, microglia in the medial basal hypothalamus regulate metabolic physiology and may be involved in both metabolic disorders and involvement of metabolism in the timing of puberty [315, 316].
Drug Addiction
Drug addiction usually begins between 12 and 17 years of age and although more men use drugs, women are at a greater risk of addiction [305, 317]. Drug use at puberty has been related to sensation seeking and impulsivity in both girls and boys [318] and in women, substance abuse varied over the menstrual cycle [317]. This leads to two hypotheses about sex differences in drug addictions: (1) sexual differentiation of the brain during the neonatal organizational period [317] and (2) the activation/ organization of sex differences in the dopaminergic and opioid reward systems at puberty [319]. Since sex differences in the DA system are due to the effects of gonadal hormones during the perinatal organizational period and the activational period at puberty, the DA hypothesis is a subset of the sexual differentiation hypothesis.
Other Addictions
There are many addictions beyond food and drug addiction: sex, gambling, and internet addictions being more common in men, and exercise addiction being more common in women. However, gambling addiction in women may be associated with depression and other psychiatric problems, while in men it is associated with impulsivity, sensation seeking, and risk taking (See [305]). Sex differences in these behaviors may be due to sex differences in reward pathways in the brain or to the activational effects of sex hormones. Other addictions, such as compulsive shopping for clothes (mainly by women) or tools and electronic equipment (mainly by men) and pyromania (mainly by men) may also be related to anxiety, depression, and other psychiatric problems [305], which are also sexually dimorphic (See below).
Sex Differences in Neuropsychiatric Disorders, Anxiety, and Depression at Puberty
Puberty has been associated with a wide range of psychopathologies and neuropsychiatric syndromes in both boys and girls [320, 321]. Twice as many women as men develop anxiety and depression after puberty and it has been proposed that this is the result of the activation of sex differences in the HPA and serotonergic systems at puberty [322]. It is noteworthy that sex differences in cortisol metabolism begin around 11 years of age and increase as puberty advances, after which men secrete more cortisol metabolites than women [323]. However, it has been suggested that the sexual differentiation of the HPG pathway during the perinatal organizational period sets the stage for the activation of sex differences in responses to stress at puberty [324] as there is a close association between the HPG and HPA pathways as discussed above. The sex differences in the development of anxiety, depression and other disorders may be the result of the interaction of stressful stimuli on the sexually dimorphic HPA system [220]. Puberty can also result in the onset of adolescent NDDs, such as schizophrenia [59, 282, 325,326,327]. Because there is significant synaptic remodeling at puberty, there is the "window of vulnerability" for the development of synaptopathies and for disruption of excitatory: inhibitory signaling ratios. Since the neuroendocrine changes that occur at puberty are all regulated by chemical signaling pathways, there is the opportunity for environmental epigenetic mechanisms to disrupt the neuroendocrine system during this critical period of brain development [280, 328].
Pediatric Infection-Triggered Neuropsychiatric Disorder
Although not particularly associated with puberty, there is a subtype of obsessive-compulsive disorder and/or tics (Tourette’s syndrome) which is caused by an infection or neuro-immune activation [320, 329]. This disorder occurs more often in males than females (65:35 ratio) and can begin before or after puberty, with a median age of 11 years old. It has been associated with Group A streptococcal (GAS) infections and the onset is abrupt (e.g., Overnight). As well as OCD it can result in anxiety and/or depression, and sensori-motor disabilities (see [329]). I include it here because of the role of the immune system in neural development and in sexual differentiation in perinatal and pubertal development.
Disorders/Differences of Sexual Development
At one time it was believed that there were only two sexes, male and female, but there can be five sexes or more [330, 331] (Table 11.2). The root causes of the differences in sexual development are a mismatch between sex chromosomes, gonadal hormones, and anatomical features [26, 332, 333]. A true hermaphrodite (Ovotesticular disorder) has both XX and XY chromosomes, both testes and ovaries, a penis and a vagina, and can secrete both androgens and estrogens. A male pseudohermaphrodite (46, XY DSD) has XY chromosomes and testes but a feminized body, with a vagina and breast development due to a lack of androgens or androgen receptors. A female pseudohermaphrodite (46, XX DSD) has XX chromosomes and ovaries but a masculinized body with a penis due to excessive androgen secretion, primarily from the adrenal cortex [332, 333]. There can also be XX males (46, XX testicular DSD) and XY sex reversal (46, XY complete gonadal dysgenesis) (see [334, 335]). These disorders of sexual differentiation are usually detected neonatally. The decision to give surgical or hormonal correction and rear these children as boys or girls is usually made shortly after birth and involves many complex issues (see [334, 335]). What concerns us here are the issues raised at puberty with respect to gender identity (whether a person feels that they are male or female), gender role (whether a person behaves as a male or female, as defined by their culture), and sexual orientation (a person’s attraction to the same or opposite sex, or both: heterosexual, bisexual, homosexual). Disorders of gender identity and role fall under the heading of “gender dysphoria.”
Gender dysphoria refers to males who identify as females and females who identify as males. Although gender of rearing is the best predictor of gender identity and role in most people with DSD [336] gender dysphoria affects up to 20% of people with DSD [337, 338]. As discussed in Sects. “Sex Determination and Sexual Differentiation” and “Sex Differences in the Brain” on sexual determination and sexual differentiation, females who are exposed to androgens neonatally are masculinized (e.g., congenital adrenal hyperplasia) and males with mutations in androgen synthesis or androgen receptors are feminized [333,334,335]. Females with CAH have XX chromosomes and are generally reared as female and that works well if the levels of prenatal androgen are low, but if there are high levels of androgens prenatally, the “girl” may decide that she is a boy and wish to have sex reassignment at puberty (See [339]). One procedure to “treat” gender dysphoria in both males and females is to suppress puberty using GnRH analogues, along with psychological support, followed by hormone therapy and gender reassignment surgery. This seems to be successful [340, 341].
Adolescent-onset gender dysphoria is increasing in frequency and is sexually dimorphic, with male-to-female gender dysphoria (transsexualism) having a rate of 6.8/100,000 and female-to-male transsexualism at 2.8/100,000 [342]. Other surveys find that more female than male adolescents report gender dysphoria, with sex ratios of up to 7.5:1 [343]. The “Dutch model” for treating adolescent gender dysphoria is to use puberty suppression around 12 years of age, hormone treatment at 16 years of age, and surgery after 18 years of age [342]. Adolescents with gender dysphoria often have anxiety and depressive disorders, but some are in danger of committing suicide [343]. The phenomenon of “rapid onset gender dysphoria” occurs in adolescents around 16 years of age in more than 80% are female [344, 345]. This is a controversial topic and seems to be a socio-cultural phenomenon rather than a neuroendocrine phenomenon [343, 346]. Time will tell.
Theories of gender dysphoria and the desire for sex change surgery focus on chromosomal sex determination, and hormonal sex differentiation during the neonatal critical period for brain organization. The focus has been on the sexual differentiation of the brain and whether gender dysphoria is the result of abnormal neuroendocrine organization of sexually dimorphic neural circuits in the brain that are activated at puberty. There is considerable evidence that perinatal sexual differentiation of the hypothalamic areas (the BNST and the third interstitial nucleus of the anterior hypothalamus (INAH-3) are two areas which underlie gender dysphoria in males. If they are not sufficiently masculinized by androgens during development, it appears that men may fail to develop a masculine gender identity and role [347,348,349,350,351]. Gender dysphoria is most likely the result of abnormalities in the organizational effects of sex chromosomes and gonadal hormones during the perinatal organizational period (see [352,353,354]). Kisspeptin neurons may also be involved in the regulation of sexual differentiation, and the development of gender identity and role and thus dysfunction of the kisspeptin system may underlie gender dysphoria [355]. In addition, the glial cells, which regulate sexual differentiation, metabolism, and the development of the HPG system, may also be involved in gender dysphoria [293, 338, 349, 356].
Summary: Theories About the Causes of Sex Differences in Neurodevelopmental Disorders: Genetic, Hormonal, Immune, and Environmental (epigenetic) Mechanisms
In this chapter I have tried to dissect all of the information on the causes of sex differences in NDDs. From the studies examined, it is clear that (1) sex differences depend on the XX and XY chromosomes; (2) sex differences depend on the gonadal steroid hormones, estrogen, and testosterone; (3) sex differences depend on the sexual differentiation of neurons and neurotransmitter pathways in the hypothalamus and related brain areas: the amygdala, hippocampus, and arcuate nucleus; and (4) sex differences depend on glial cells and gliotransmitters. There is a critical perinatal organizational period for sexual differentiation with masculinization by gonadal androgens occurring before feminization by estrogens. During this critical period many cells in the body are sexually differentiated. Finally, at puberty there is a surge in gonadal steroids regulated by the hypothalamus which activates the sex differences determined perinatally and reorganizes many neuroendocrine brain circuits. Since hormones, neurotransmitters, and neuropeptides act via epigenetic mechanisms to regulate gene transcription in a sexually dimorphic fashion, endocrine-disrupting chemicals in the environment can modulate these same pathways and alter the normal patterns of sexual differentiation during perinatal critical periods.
Finally, it must be remembered that there is the potential for sex differences in gene expression in virtually every cell in the body, including the liver, adipose tissue, muscle, and brain [357, 358]. “Male biased” genes are expressed more highly in males and “female-biased” genes are expressed more highly in females. Most sexually dimorphic genes are located on the sex chromosomes, with more female-biased genes on the X chromosome and more male-biased genes on the Y chromosome, but many autosomes also contain sexually dimorphic gene expression in a tissue-specific fashion [358]. The sex difference in gene expression may be due to the actions of the gonadal hormones as transcription factors. Sex differences in gene expression profiles in brain tissues may underlie the sex differences in neurodevelopmental and neurodegenerative disorders [295, 359]. Likewise, sex differences in gene expression profiles in nongonadal tissues in the body may be associated with sex differences in the incidence of cancer, atherosclerosis, obesity, and responses to drugs [358, 360, 361]. Thus, it is not surprising that there are sex differences in the incidence of NDDs, but it is difficult to pinpoint the causes of such sex differences in individuals. Every patient is their own experiment.
References
Glucksmann A. Sexual dimorphism in mammals. Biol Rev. 1974;49:423–75. https://doi.org/10.1111/j.1469-185X.1974.tb01171.x.
Hoyenga KB, Hoyenga KT. The question of sex differences: psychological, cultural, and biological issues. Boston (Mass.): Little, Brown; 1979.
Snell DM, Turner JMA. Sex chromosome effects on male-female differences in mammals. Curr Biol. 2018;28:R-1313-R1324. https://doi.org/10.1016/j.cub.2018.09.018.
Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, De Vries GJ, Epperson CN, Govindan R, Klein SL, Lonardo A, Maki PM, McCullough LD, Regitz-Zagrosek V, Regensteiner JG, Rubin JB, Sandberg K, Suzuki A. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82. https://doi.org/10.1016/S0140-6736(20)31561-0.
Pearse RV 2nd, Young-Pearse TL. Lost in translational biology: understanding sex differences to inform studies of diseases of the nervous system. Brain Res. 2019;1722:146352. https://doi.org/10.1016/j.brainres.2019.146352.
Zagni E, Simoni L, Colombo D. Sex and gender differences in central nervous system-related disorders. Neurosci J. 2016;2016:2827090. https://doi.org/10.1155/2016/2827090.
Newhouse A, Chemali Z. Neuroendocrine disturbances in neurodegenerative disorders: a scoping review. Psychosomatics. 2020;61(2):105–15. https://doi.org/10.1016/j.psym.2019.11.002.
Schug TT, Blawas AM, Gray K, Heindel JJ, Lawler CP. Elucidating the links between endocrine disruptors and neurodevelopment. Endocrinology. 2015;156:1941–51. https://doi.org/10.1210/en.2014-1734.
D’Souza H, Karmiloff-Smith A. Neurodevelopmental disorders. WIREs. Cogn Sci. 2017;8:1–10. https://doi.org/10.1002/wcs.1398.
Bishop DVM. Which neurodevelopmental disorders get researched and why? PlosOne. 2010;5(11):e15112. https://doi.org/10.1371/journal.pone.0015112.
Hanamsagar R, Bilbo SD. Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development. J Steroid Biochem Mol Biol. 2016;160:127–33. https://doi.org/10.1016/j.jsbmb.2015.09.039.
Clayton JA. Sex influences in neurological disorders: case studies and perspectives. Dialogues Clin Neurosci. 2016;18:357–60. https://doi.org/10.31887/DCNS.2016.18.4/jclayton.
Polyak A, Rosenfeld JA, Girirajan S. An assessment of sex bias in neurodevelopmental disorders. Genome Med. 2015;7:94. https://doi.org/10.1186/s13073-015-0216-5.
Arnold AP, McCarthy MM. Sexual differentiation of the brain and behaviour: a primer. In: Pfaff DW, Volkow ND, editors. Neuroscience in the 21st century: from basic to clinical. New York: Springer; 2016. p. 2139–68.
Arnold AP. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav. 2009;55:570–8. https://doi.org/10.1016/j.yhbeh.2009.03.011.
Arnold AP. A general theory of sexual differentiation. J Neurosci Res. 2017;95:291–300. https://doi.org/10.1002/jnr.23884.
Arnold AP. Rethinking sex determination of non-gonadal tissues. Curr Top Dev Biol. 2019;134:289–315. https://doi.org/10.1016/bs.ctdb.2019.01.003.
Arnold AP. Sexual differentiation of brain and other tissues: Five questions for the next 50 years. Horm Behav. 2020;120:104691. https://doi.org/10.1016/j.yhbeh.2020.104691.
McCarthy MM. A new view of sex differentiation of mammalian brain. J Comp Physiol A. 2019;206:369–78. https://doi.org/10.1007/s00359-019-01376-8.
Eggers S, Sinclair A. Mammalian sex determination—insights from humans and mice. Chromosome Res. 2012;20:215–38. https://doi.org/10.1007/s10577-012-9274-3.
Eggers S, Ohnesorg T, Sinclair A. Genetic regulation of mammalian gonad development. Nat Rev Endocrinol. 2014;10:673–83. https://doi.org/10.1038/nrendo.2014.163.
Sekido R. The potential role of SRY in epigenetic gene regulation during brain sexual differentiation in mammals. Adv Genet. 2014;86:135–65. https://doi.org/10.1016/B978-0-12-800222-3.00007-3.
Spiller C, Koopman P, Bowles J. Sex determination in the mammalian germline. Annu Rev Genet. 2017;51:265–85. https://doi.org/10.1146/annurev-genet-120215-035449.
Stevant I, Nef S. Genetic control of gonadal sex determination and development. Trends Genet. 2019;35:346–58. https://doi.org/10.1016/j.tig.2019.02.004.
Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiol Rev. 2007;87:1–28. https://doi.org/10.1152/physrev.00009.2006.
Gomes NL, Chetty T, Jorgensen A, Mitchell RT. Disorders of sex development—novel regulators, impacts on fertility, and options for fertility preservation. Int J Mol Sci. 2020;21:2282. https://doi.org/10.3390/ijms21072282.
Case LK, Teuscher C. Y genetic variation and phenotypic diversity in health and disease. Biol Sex Differ. 2015;6:6. https://doi.org/10.1186/s13293-015-0024-z.
Dewing P, Chiang CWK, Sinchak K, Sim H, Fernagut P-O, Kelly S, Chesselet M-F, Micevych PE, Albercht KH, Harley VR, Vilain E. Direct regulation of adult brain function by the male-specific factor SRY. Curr Biol. 2006;16:415–20. https://doi.org/10.1016/j.cub.2006.01.017.
Wilson CA, Davies DC. The control of sexual differentiation of the reproductive system and brain. Reproduction. 2007;133:331–59. https://doi.org/10.1530/REP-06-0078.
Arnold AP, Reue K, Eghbali M, Vilain E, Chen X, Ghahramani N, Itoh Y, Li J, Link JC, Ngun T, Williams-Burris SM. The importance of having two X chromosomes. Phil Trans R Soc B. 2016;371:20150113. https://doi.org/10.1098/rstb.2015.0113.
Finney EL, Finlayson C, Rosoklija I, Leeth EA, Chen D, Yerkes EB, Cheng EY, Johnson EK. Prenatal detection and evaluation of differences of sex development. J Pediatr Urol. 2020;16(1):89–96. https://doi.org/10.1016/j.jpurol.2019.11.005.
Bashamboo A, McElreavey K. Mechanism of sex determination in humans: insights from disorders of sex development. Sex Dev. 2016;10(5-6):313–25. https://doi.org/10.1159/000452637.
Gunes SO, Mahmutoglu AM, Agarwal A. Genetic and epigenetic effects in sex determination. Birth Defects Res C. 2016;108(4):321–36. https://doi.org/10.1002/bdrc.21146.
Blecher SR, Erickson RP. Genetics of sexual development: a new paradigm. Am J Med Genet Part A. 2007;143A:3054–68. https://doi.org/10.1002/ajmg.a.32037.
Tartaglia NR, Howell S, Sutherland A, Wilson R, Wilson L. A review of trisomy X (47, XXX). Orphanet J Rare Dis. 2010;5:8. https://doi.org/10.1186/1750-1172-5-8.
Majzoub A, Arafa M, Starks C, Elbardisi H, Said AS, Sabanegh E Jr. 46 XX karyotype during male fertility evaluation; case series and literature reviews. Asian Journal of Andrology. 2017;19:168–72. https://doi.org/10.4103/1008-682X.181224.
Kim IW, Khadilkar AC, Ko EY, Sabanegh ES Jr. 47, XYY syndrome and male infertility. Reviews in Urology. 2013;15:188–96.
Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, Reynolds A, Fenton L, Albrecht L, Ross J, Visootsak J, Hansen R, Hagerman R. A new look at XXYY syndrome: medical and psychological features. Am J Med Genet Part A. 2008;146A:1509–22. https://doi.org/10.1002/ajmg.a.32366.
Piferrer F. Epigenetics of sex determination and gonadogenesis. Dev Dyn. 2013;242:360–70. https://doi.org/10.1002/dvdy.23924.
Tachibana M. Epigenetics of sex determination in mammals. Reprod Med Biol. 2016;15:59–67. https://doi.org/10.1007/s12522-015-0223-7.
Miyawaki S, Tachibana M. Role of epigenetic regulation in mammalian sex determination. Curr Top Dev Biol. 2019;134:195–221. https://doi.org/10.1016/bs.ctdb.2019.01.008.
Neri G, Schwartz CE, Lubs HA, Stevenson RE. X-linked intellectual disability update 2017. Am J Med Genet. 2018;176A:1375–88. https://doi.org/10.1002/ajmg.a.38710.
Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Human Genomics. 2019;13(1):2. https://doi.org/10.1186/s40246-018-0185-z.
Iwase S, Berube NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A. Epigenetic etiology of intellectual disability. J Neurosci. 2017;8:10773–82. https://doi.org/10.1523/JNEUROSCI.1840-17.2017.
Millan MJ. An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy. Neuropharmacology. 2013;68:2–82. https://doi.org/10.1016/j.neuropharm.2012.11.015.
Chahil G, Yelam A, Bollu PC. Rett syndrome in males: a case report and review of literature. Cureus. 2018;10:e3414. https://doi.org/10.7759/cureus.3414.
Moog U, Smeets EEJ, van Roozendaal KE, Schoenmakers S, Herbergs J, Schoonbrood-Lenssen AMJ, Schrander-Stumpel CTRM. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol. 2003;7:5–12. https://doi.org/10.1016/S1090-3798(02)00134-4.
Szafranski P, Golla S, Jin W, Fang P, Hixson P, Matalon R, Kinney D, Bock H-G, Craigen W, Smith JL, Bi W, Patel A, Cheung SW, Bacino CA, Stankiewicz P. Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications. Eur J of Human Genet. 2015;23:915–21. https://doi.org/10.1038/ejhg.2014.217.
Bassani S, Zapata J, Gerosa L, Moretto E, Murru L, Passafaro M. The neurobiology of X-linked intellectual disability. The Neuroscientist. 2013;19:541–52. https://doi.org/10.1177/1073858413493972.
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev. 2016;16:626–38. https://doi.org/10.1038/nri.2016.90.
vom Steeg LG, Klien SL. SeXX matters in infectious disease pathogenesis. PLOS Pathog. 2016;12:e1005374. https://doi.org/10.1371/journal.ppat.1005374.
Harper A, Flanagan KL. Effect of sex on vaccination outcomes: important but frequently overlooked. Current opinion in pharmacology. 2018;41:122–7. https://doi.org/10.1016/j.coph.2018.05.009.
Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9–15. https://doi.org/10.1093/trstmh/tru167.
Andersen SL. Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev. 2003;27(1-2):3–18. https://doi.org/10.1016/s0149-7634(03)00005-8.
Bakker J. Chapter 1: Sex differentiation: organizing effects of sex hormones. In: Kreukels BPC, et al., editors. Gender dysphoria and disorders of sex development. New York, NY: Springer Press; 2014. p. 3–23.
Manoli DS, Tollkuhn J. Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease. Ann N Y Acad Sci. 2018;1420(1):26–45. https://doi.org/10.1111/nyas.13564.
McCarthy MM, Herold K, Stockman SL. Fast, furious and enduring: Sensitive versus critical periods in sexual differentiation of the brain. Physiol Behav. 2018;187:13–9. https://doi.org/10.1016/j.physbeh.2017.10.030.
Phoenix CH, Goy RW, Gerall AA, Young WC. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology. 1959;65:369–82. https://doi.org/10.1210/endo-65-3-369.
Schulz KM, Molenda-Figueira HA, Sisk CL. Back to the future: the organization-activational hypothesis adapted to puberty and adolescence. Horm Behav. 2009;55:597–604. https://doi.org/10.1016/j.yhbeh.2009.03.010.
Schulz KM, Sisk CL. The organizing actions of adolescent gonadal steroid hormones on brain and behavioral development. Neurosci Biobehav Rev. 2016;70:148–58. https://doi.org/10.1016/j.neubiorev.2016.07.036.
Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci. 2004;7:1040–70. https://doi.org/10.1038/nn1326.
Forger NG, Strahan JA, Castillo-Ruiz A. Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system. Front Neuroendocrinol. 2016;40:67–86. https://doi.org/10.1016/j.yfrne.2016.01.001.
McCarthy MM, Nugent BM. Epigenetic contributions to hormonally-mediated sexual differentiation of the brain. J Neuroendocrinol. 2013;25:1133–40. https://doi.org/10.1111/jne.12072.
Shepard KN, Michopoulos V, Toufexis DJ, Wilson ME. Genetic, epigenetic and environmental impact on sex differences in social behaviour. Physiol Behav. 2009;97:157–70. https://doi.org/10.1016/j.physbeh.2009/02.016.
Weaver ICG. Integrating early life experience, gene expression, brain development, and emergent phenotypes: Unraveling the thread of nature via nurture. Adv Genet. 2014;86:277–307. https://doi.org/10.1016/B978-0-12-800222-3.00011-5.
MacLusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science. 1981;211:1294–303. https://doi.org/10.1126/science.6163211.
Shay DA, Vieira-Potter VJ, Rosenfeld CS. Sexually dimorphic effects of aromatase on neurobehavioral responses. Front Mol Neurosci. 2018;11:374. https://doi.org/10.3389/fnmol.2018.00374.
Roselli CE, Liu M, Hurn PD. Brain aromatization: classical roles and new perspectives. Semin Reprod Med. 2009;27:207–17. https://doi.org/10.1055/s-0029-1216274.
Bakker J, De Mees C, Douhard Q, Balthazart J, Gabant P, Szpirer J, Szpirer C. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci. 2006;9:220–6. https://doi.org/10.1038/nn1624.
Rizzo A, Galgano M, Mutinati M, Sciorsci RL. Alpha-fetoprotein in animal reproduction. Res Vet Sci. 2019;123:281–5. https://doi.org/10.1016/j.rvsc.2019.01.028.
Motta-Mena NV, Puts DA. Endocrinology of human female sexuality, mating, and reproductive behavior. Horm Behav. 2017;91:19–35. https://doi.org/10.1016/j.yhbeh.2016.11.012.
Luoto S, Rantala MJ. On estrogenic casualization of the human brain and behaviour. Horm Behav. 2018;97:1–2. https://doi.org/10.1016/j.yhbeh.2017.07.017.
Puts D, Motta-Mena NV. Is human brain masculinization estrogen receptor-mediated? Horm Behav. 2018;97:3–4. https://doi.org/10.1016/j.yhbeh.2017.07.018.
Brock O, Baum MJ, Bakker J. The development of female sexual behaviour requires prepubertal estradiol. J Neurosci. 2011;31:5574–8. https://doi.org/10.1523/JNEUROSCI.0209-11.2011.
Rosenfeld CS. Brain sexual differentiation and requirement of SRY: why or why not? Front Neurosci. 2017;11:632. https://doi.org/10.3389/fnins.2017.00632.
Nugent DM, Wright CL, Shetty AC, Hodes GE, Lenz KM, Mahurkar A, Russo SJ, Devine SE, McCarthy MM. Brain feminization requires active repression of masculinization via DNA methylation. Nat Neurosci. 2015;18:690–70. https://doi.org/10.1038/nn.3988.
Kubota T, Miyake K, Hirasawa T. Epigenetics in neurodevelopmental and mental disorders. Med Epigenet. 2013;1:52–9. https://doi.org/10.1159/000354718.
Ricq EL, Hooker JM, Haggarty SJ. Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation. Psychiatry Clin Neurosci. 2016;70:536–50. https://doi.org/10.1111/pcn.12426.
Szyf M. Prospects for the development of epigenetic drugs for CNS conditions. Nat Rev. 2015;14:461–74. https://doi.org/10.1038/nrd4580.
Filová B, Ostatníková D, Celec P, Hodosy J. The effect of testosterone on the formation of brain structures. Cells Tissues Organs. 2013;197(3):169–77. https://doi.org/10.1159/000345567.
Carruth LL, Reisert I, Arnold AP. Sex chromosome genes directly affect brain sexual differentiation. Nat Neurosci. 2002;5:933–40. https://doi.org/10.1038/nn922.
McCarthy MM. Sex differences in neuroimmunity as an inherent risk factor. Neuropsychopharmacology. 2018;44(1):38–44. https://doi.org/10.1038/s41386-018-0138-1.
Villa A, Della Torre S, Maggi A. Sexual differentiation of microglia. Front Neuroendocrinol. 2019;52:156–64. https://doi.org/10.1016/j.yfrne.2018.11.003.
Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med. 2006;13:54–62. https://doi.org/10.1016/j.molmed.2006.12.005.
Perea G, Navarrete M, Araque A. Tripartite synapse: astrocytes process and control synaptic information. Trend Neurosci. 2009;32:421–31. https://doi.org/10.1016/j.tins.2009.05.001.
Schiera G, Di Liegro CM, Di Liegro I. Cell-to-cell communication in learning and memory: from neuro- and glio-transmission to information exchange mediated by extracellular vesicles. Int J Mol Sci. 2020;21(1):266. https://doi.org/10.3390/ijms21010266.
VanRyzin JW, Marquardt AE, Pickett LA, McCarthy MM. Microglia and sexual differentiation of the developing brain: a focus on extrinsic factors. Glia. 2019;2019:1–14. https://doi.org/10.1002/glia.23740.
VanRyzin JW, Pickett LA, McCarthy MM. Microglia: driving critical periods and sexual differentiation of the brain. Dev Neurobiol. 2018;78(6):580–92. https://doi.org/10.1002/dneu.22569.
Amateau SK, McCarthy MM. Sexual differentiation of astrocyte morphology in the developing rat preoptic area. J Neuroendocrinol. 2002;14:904–10. https://doi.org/10.1046/j.1365-2826.2002.00858.x.
Schwarz JM, Sholar PW, Bilbo SD. Sex differences in microglial colonization of the developing rat brain. J Neurochem. 2012;120:948–63. https://doi.org/10.1111/j.1471-4159.2011.07630.x.
Pfau DR, Hobbs NJ, Breedlove SM, Jordan CL. Sex and laterality differences in medial amygdala neurons and astrocytes of adult mice. J Comp Neurol. 2016;524:2492–502. https://doi.org/10.1002/cne.23964.
Bordt EA, Ceasrine AM, Bilbo SD. Microglia and sexual differentiation of the developing brain: A focus on ontogeny and intrinsic factors. Glia. 2019;68:1085–99. https://doi.org/10.1002/glia.23753.
Frost JL, Schafer DP. Microglia: architects of the developing nervous system. Trends Cell Biol. 2016;26:587–97. https://doi.org/10.1016/j.tcb.2016.02.006.
Arnold AP. Sex chromosomes and brain gender. Nat Rev. 2004;5:701–8. https://doi.org/10.1038/nrn1494.
Joel D, Garcia-Falgueras A, Swaab D. The complex relationships between sex and the brain. The Neuroscientist. 2020;26(2):156–69. https://doi.org/10.1177/1073858419867298.
Rhodes ME, Rubin RT. Functional sex differences (‘sexual diergism’) of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res Rev. 1999;30:135–52. https://doi.org/10.1016/s0165-0173(99)00011-9.
Ruigrok ANV, Salimi-Khorshidi G, Lai M-C, Baron-Cohen S, Lombardo MV, Tait RJ, Suckling J. A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev. 2014;39:34–50. https://doi.org/10.1016/j.neubiorev.2013.12.004.
Koolschijn PCMP, Crone EA. Sex differences and structural brain maturation from childhood to early adulthood. Dev Cogn Neurosci. 2013;5:106–18. https://doi.org/10.1016/j.dcn.2013.02.003.
Ritchie SJ, Cox SR, Shen X, Lombardo MV, Reus LM, Alloza C, Harris MA, Alderson HL, Hunter S, Neilson E, Liewald DCM, Auyeung B, Whalley HC, Lawrie SM, Gale CR, Bastin ME, McIntosh AM, Deary IJ. Sex differences in the adult human brain: Evidence from 5216 UK biobank participants. Cereb Cortex. 2018;28:2959–75. https://doi.org/10.1093/cercor/bhy109.
Swaab DF, Chung WCJ, Kruijver FPM, Hofman MA, Hestiantoro A. Sex differences in the hypothalamus in the different stages of human life. Neurobiol Aging. 2003;24:S1–S16. https://doi.org/10.1016/S0197-4580(03)00059-9.
Woodson JC and Gorski RA. Structural sex differences in the mammalian brain: Reconsidering the male/female dichotomy. In A Mutsumoto (Ed.), Sexual differentiation of the brain. Boca Roton, FL, CRC Press. 2000; (pp. 229–255).
Xin J, Zhang Y, Tang Y, Yang Y. Brain differences between men and women: Evidence from deep learning. Front Neurosci. 2019;13:185. https://doi.org/10.3389/fnins.2019.00185.
Kiesow H, Dunbar RIM, Kable JW, Kalenscher T, Vogeley K, Schilbach L, Marquand AF, Wiecki TV, Bzdock D. 10,000 social brains: sex differentiation in human brain anatomy. Sci Adv. 2020;6:eaaz1170. https://doi.org/10.1126/sciadv.aaz1170.
Spring S, Lerch JP, Henkelman RM. Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. NeuroImage. 2007;35:1424–33. https://doi.org/10.1016/j.neuroimage.2007.02.023.
Tobet SA, Hanna IK. Ontogeny of sex differences in the mammalian hypothalamus and preoptic area. Cell Mol Neurobiol. 1997;17:565–601. https://doi.org/10.1023/a:1022529918810.
Billing A, Correia H, Kelly DA, Li GL, Bergan JF. Synaptic connections of aromatase circuits in the medial amygdala are sex specific. Eneuro. 2020;7:1–11. https://doi.org/10.1523/eneuro.0489-19.2020.
Bodo C. A role for the androgen receptor in the sexual differentiation of the olfactory system in mice. Brain Res Rev. 2008;57:321–31. https://doi.org/10.1016/j.brainresrev.2007.08.008.
Cherry JA, Baum MJ. Sex differences in main olfactory system pathways involved in psychosexual function. Genes Brain Behav. 2020;19:e12618. https://doi.org/10.1111/gbb.12618.
Garcia-Falgueras A, Junque C, Gimenez M, Caldu X, Segovia S, Guillamon A. Sex differences in the human olfactory system. Brain Res. 2006;1116:103–11. https://doi.org/10.1016/j.brainres.2006.07.115.
Moffatt CA. Steroid hormone modulation of olfactory processing in the cortex of socio-sexual behaviours in rodents and humans. Brain Res Rev. 2003;43:192–206. https://doi.org/10.1016/s0165-0173(03)00208-x.
Lenz KM, Nugent BR, McCarthy MM. Sexual differentiation of the rodent brain: Dogma and beyond. Front Neurosci. 2012;6:26. https://doi.org/10.3389/fnins.2012.00026.
Tsukahara S. Sex differences and the roles of sex steroids in apoptosis of sexually dimorphic nuclei of the preoptic area in postnatal rats. J Neuroendocrinol. 2009;21:370–6. https://doi.org/10.1111/j.1365-2826.2009.01855.x.
Wei Y-C, Wang S-R, Jiao Z-L, Zhang W, Lin J-K, Li X-Y, Li S-S, Zhang X, Xu X-H. Medial preoptic area in mice is capable of mediating sexually dimorphic behaviours regardless of gender. Nat Commun. 2018;9:279. https://doi.org/10.1038/s41467-017-02648-0.
Chung WCJ, De Vries GJ, Swaab DF. Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. J Neurosci. 2002;22:1027–33. https://doi.org/10.1523/JNEUROSCI.22-03-01027.2002.
Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. 2016;21:450–63. https://doi.org/10.1038/mp.2016.1.
Tsukahara S, Morishita M. Sexually dimorphic formation of the preoptic area and the bed nucleus of the stria terminalis by neuroestrogens. Front Neurosci. 2020;14:797. https://doi.org/10.3389/fnins.2020.00797.
Uchida K, Otsuka H, Morishita M, Tsukahara S, Sato S, Sato T, Sakimura K, Itoi K. Female-biased sexual dimorphism of corticotropin-releasing factor neurons in the bed nucleus of the stria terminalis. Biol Sex Differ. 2019;10:6. https://doi.org/10.1186/s13293-019-0221-2.
Davis EC, Shryne JE, Gorski RA. Structural sexual dimorphisms in the anteroventral periventricular nucleus of the rat hypothalamus are sensitive to gonadal steroids perinatally, but develop peripubertally. Neuroendocrinology. 1996;63:142–8. https://doi.org/10.1159/000126950.
Simerly RB, Zee MC, Pendleton JW, Lubahn DB, Korach KS. Estrogen receptor-dependent sexual differentiation of dopaminergic neurons in the preoptic region of the mouse. Proc Natl Acad Sci USA. 1997;94:14077–82. https://doi.org/10.1073/pnas.94.25.14077.
Krause WC, Ingraham HA. Origins and functions of the ventrolateral VMH: A complex neuronal cluster orchestrating sex differences in metabolism and behaviour. Adv Exp Med Biol. 2017;1043:199–213. https://doi.org/10.1007/978-3-319-70178-3_10.
Yang CF, Chiang MC, Gray DC, Prabhakaran M, Alvarado M, Juntti SA, Unger EK, Wells JA, Shah NM. Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males. Cell. 2013;153:896–909. https://doi.org/10.1016/j.cell.2013.04.017.
Yang CF, Shah NM. Representing sex in the brain, one module at a time. Neuron. 2014;82(2):261–78. https://doi.org/10.1016/j.neuron.2014.03.029.
Kight KE, McCarthy MM. Androgens and the developing hippocampus. Biol Sex Differ. 2020;11:30. https://doi.org/10.1186/s13293-020-00307-6.
Brandt N, Loffler T, Fester L, Rune GM. Sex-specific features of spine densities in the hippocampus. Sci Rep. 2020;10:14405. https://doi.org/10.1038/s41598-020-68371-x.
Koss WA, Frick KM. Sex differences in hippocampal function. J Neurosci Res. 2017;95:539–62. https://doi.org/10.1002/jnr.23864.
Siddiqui A, Romeo RD. Sex differences and similarities in hippocampal cellular proliferation and the number of immature neurons during adolescence in rats. Dev Neurosci. 2019;41:132–8. https://doi.org/10.1159/000502056.
Yagi S, Galea LAM. Sex differences in hippocampal cognition and neurogenesis. Neuropsychopharmacology. 2019;44:200–13. https://doi.org/10.1038/s41386-018-0208-4.
Bundy JL, Vied C, Nowakowski RS. Sex differences in the molecular signature of the developing mouse hippocampus. BMC Genomics. 2017;18:237. https://doi.org/10.1186/s12864-017-3608-7.
Bird CM, Burgess N. The hippocampus and memory: Insights from spatial processing. Nat Rev Neurosci. 2008;9:182–94. https://doi.org/10.1038/nrn2335.
Bubb EJ, Kinnavane L, Aggleton JP. Hippocampal-diencephalic-cingulate networks for memory and emotion: an anatomical guide. Brain Neurosci Adv. 2017;1:1–20. https://doi.org/10.1177/2398212817723443.
Li Y, Shen M, Stockton ME, Zhao X. Hippocampal deficits in neurodevelopmental disorders. Neurobiol Learn Mem. 2019;165:106945. https://doi.org/10.1016/j.nlm.2018.10.001.
Cooke BM. Steroid-dependant plasticity in the medial amygdala. J Neurosci. 2006;138:997–1005. https://doi.org/10.1016/j.neuroscience.2005.06.018.
Kilpatrick LA, Zald DH, Pardo JV, Cahill LF. Sex-related differences in amygdala functional connectivity during resting conditions. NeuroImage. 2006;30:452–61. https://doi.org/10.1016/j.neuroimage.2005.09.065.
Uematsu A, Matsui M, Tanaka C, Takahashi T, Noguchi K, Suzuki M, Nishijo H. Developmental trajectories of amygdala and hippocampus from infancy to early adulthood in healthy individuals. PLoS ONE. 2012;7:e46970. https://doi.org/10.1371/journal.pone.0046970.
Kang N, McCarthy EA, Cherry JA, Baum MJ. A sex comparison of the anatomy and function of the main olfactory bulb-medial amygdala projection in mice. Neuroscience. 2011;172:196–204. https://doi.org/10.1016/j.neuroscience.2010.11.003.
Bangasser DA, Wiersielis KR, Khantsis S. Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress. Brain Res. 2016;1641:177–88. https://doi.org/10.1016/j.brainres.2015.11.021.
Guillamón A, de Blas MR, Segovia S. Effects of sex steroids on the development of the locus coeruleus in the rat. Brain Res. 1988;468(2):306–10. https://doi.org/10.1016/0165-3806(88)90143-5.
Pinos H, Collado P, Rodriguez-Zafra M, Rodriguez C, Segovia S, Guillamon A. The development of sex differences in the locus coeruleus of the rat. Brain Res Bull. 2001;56:73–8. https://doi.org/10.1016/s0361-9230(01)00540-8.
Nieuwenhuys R. Chemoarchitecture of the brain. Berlin Heidelberg, Germany: Springer-Verlag; 1985.
Matos HY, Hernandez-Pineda D, Charpentier CM, Rusk A, Corbin JG, Jones KS. Sex differences in biophysical signatures across molecularly defined medial amygdala neuronal subpopulations. eNeuro. 2020; https://doi.org/10.1523/ENEURO.0035-20.2020.
Polston EK, Simerly RB. Sex-specific patterns of galanin, cholecystokinin, and substance P expression in neurons of the principal bed nucleus of the stria terminalis are differentially reflected within three efferent preoptic pathways in the juvenile rat. The Journal of Comparative neurology. 2003;465:551–9. https://doi.org/10.1002/cne.10841.
Xu X, Coats JK, Yang CF, Wang A, Ahmed OM, Alvarado M, Izumi T, Shah NM. Modular genetic control of sexually dimorphic behaviours. Cell. 2012;148:596–607. https://doi.org/10.1016/j.cell.2011.12.018.
Giacobini E, Pepeu G. Sex and gender differences in the brain cholinergic system and in the response to therapy of Alzheimer disease with cholinesterase inhibitors. Curr Alzheimer Res. 2018;15:1077–84. https://doi.org/10.2174/1567205015666180613111504.
Mitsushima D. Sex differences in the septo-hippocampal cholinergic system in rats: Behavioural consequences. Curr Top Behav Neurosci. 2010;8:57–71. https://doi.org/10.1007/7854_2010_95.
McCarthy MM, Auger AP, Perrot-Sinal TS. Getting excited about GABA and sex differences in the brain. Trends Neurosci. 2002;25:307–12. https://doi.org/10.1016/s0166-2236(02)02182-3.
Polston EK, Gu G, Simerly RB. Neurons in the principal nucleus of the bed nuclei of the stria terminalis provide a sexually dimorphic GABAergic input to the anteroventral periventricular nucleus of the hypothalamus. Neuroscience. 2004;123:793–803. https://doi.org/10.1016/j.neuroscience.2003.09.034.
de Vries GJ. Sex differences in neurotransmitter systems. J Neuroendocrinol. 1990;2:1–13. https://doi.org/10.1111/j.1365-2826.1990.tb00385.x.
Knoedler JR, Shah NM. Molecular mechanisms underlying sexual differentiation of the nervous system. Curr Opin Neurobiol. 2018;53:193–87. https://doi.org/10.1016/j.conb.2018.09.005.
Labonte B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh Y-HE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, Kronman H, Pfau M, Obradovic ALJ, Dong Y, Neve RL, Russo S, Kasarskis A, Tamminga C, Mechawar N, Turecki G, Zhang B, Shen L, Nestler EJ. Sex-specific transcriptional signatures in human depression. Nat Med. 2017;23:1102–11. https://doi.org/10.1038/nm.4386.
Bagni C, Zukin SR. A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron. 2019;101:1070–88. https://doi.org/10.1016/j.neuron.2019.02.041.
Reig-Viader R, Sindreu C, Bayes A. Synaptic proteomics as a means to identify the molecular basis of mental illness: Are we getting there? Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:353–61. https://doi.org/10.1016/j.pnpbp.2017.09.011.
Wang X, Kery R, Xiong Q. Synaptopathology in autism spectrum disorders: Complex effects of synaptic genes on neural circuits. Prog Neuropsychopharmacol Biol Psychiatry. 2018b;84:398–415. https://doi.org/10.1016/j.pnpbp.2017.09.026.
Ribic A, Biederer T. Emerging roles of synaptic organizers in the regulation of critical periods. Neural Plast. 2019;2019:1538137. https://doi.org/10.1155/2019/1538137.
Bonnycastle K, Davenport EC, Cousin MA. Presynaptic dysfunction in neurodevelopmental disorders: insights from the synaptic vesicle life cycle. J Neurochem. 2020:1–29. https://doi.org/10.1111/jnc.15035.
Caldeira GL, Peca J, Carvalho AL. New insights on synaptic dysfunction in neuropsychiatric disorders. Curr Opin Neurobiol. 2019;57:62–70. https://doi.org/10.1016/j.conb.2019.01.004.
Guang S, Pang N, Deng X, Yang L, He F, Wu L, Chen C, Yin F, Peng J. Synaptopathology involved in autism spectrum disorder. Front Cell Neurosci. 2018;12:470. https://doi.org/10.3389/fncel.2018.00470.
Parra-Damas A, Saura CA. Synapse-to-nucleus signaling in neurodegenerative and neuropsychiatric disorders. Biol Psychiatry. 2019;86(2):87–96. https://doi.org/10.1016/j.biopsych.2019.01.006.
Premachandran H, Zhao M, Arruda-Carvalho M. Sex differences in the development of the rodent corticolimbic system. Front Neurosci. 2020;14:583477. https://doi.org/10.3389/fnins.2020.583477.
Rugarn O, Hammar M, Theodorsson A, Theodorsson E, Stenfors C. Sex differences in neuropeptide distribution in the rat brain. Peptides. 1999;20:81–6. https://doi.org/10.1016/S0196-9781(98)00139-9.
Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62(8):847–55. https://doi.org/10.1016/j.biopsych.2007.03.001.
Gatto CL, Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci. 2010;2:4. https://doi.org/10.3389/fnsyn.2010.00004.
Lopatina OL, Malinovskaya NA, Komleva YK, Gorina YV, Shuvaev AN, Olovyannikova RY, Belozor OS, Belova OA, Higashida H, Salmina AB. Excitation/inhibition imbalance and impaired neurogenesis in neurodevelopmental and neurodegenerative disorders. 2019;30:807–20. https://doi.org/10.1515/revneuro-2019-0014.
Jašarević E, Morrison KE, Bale TL. Sex differences in the gut microbiome-brain axis across the lifespan. Philos Trans R Soc London. Series B, Biol Sci. 2016;371(1688):20150122. https://doi.org/10.1098/rstb.2015.0122.
Lenz KM, Nugent BM, Haliyur R, McCarthy MM. Microglia are essential to masculinization of brain and behaviour. J Neurosci. 2013;33:2761–72. https://doi.org/10.1523/JNEUROSCI.1268-12.2013.
Weinhard L, Neniskyte U, Vadisiute A, di Bartolomei G, Aygun N, Riviere L, Zonfrillo F, Dymecki S, Gross C. Sexual dimorphism of microglia and synapses during mouse postnatal development. Dev Neurobiol. 2018;78:618–26. https://doi.org/10.1002/dneu.22568.
Bar E, Barak B. Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders. Glia. 2019;67:2125–42. https://doi.org/10.1002/glia.23637.
Petrelli F, Pucci L, Bezzi P. Astrocytes and microglia and their potential link with autism spectrum disorders. Front Cell Neurosci. 2016;10:21. https://doi.org/10.3389/fncel.2016.00021.
Sloan SA, Barres BA. Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders. Curr Opin Neurobiol. 2014;27:75–81. https://doi.org/10.1016/j.conb.2014.03.005.
Bordeleau M, Carrier M, Luheshi GN, Tremblay M-E. Microglia along sex lines: from brain colonization, maturation and function, to implication in neurodevelopmental disorders. Semin Cell Dev Biol. 2019;94:152–63. https://doi.org/10.1016/j.semcdb.2019.06.001.
Garcia-Segura LM, Melcangi RC. Steroids and glial cell function. Glia. 2006;54:485–98. https://doi.org/10.1002/glia.20404.
Bollinger JL, Salinas I, Fender E, Sengelaub DR, Wellman CL. Gonadal hormones differentially regulate sex-specific stress effects on glia in the medial prefrontal cortex. J Neuroendocrinol. 2019;31:e12762. https://doi.org/10.1111/jne.12762.
Duong P, Tenkorang MAA, Trieu J, McCuiston C, Rybalchenko N, Cunningham RL. Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment. Biol Sex Differ. 2020;11:12. https://doi.org/10.1186/s13293-020-0283-1.
Salas IH, Burgado J, Allen NJ. Glia: Victims or villains of the aging brain? Neurobiol Dis. 2020;143:105008. https://doi.org/10.1016/j.nbd.2020.105008.
Erny D, de Angelis ALH, Prinz M. Communicating systems in the body: how microbiota and microglia cooperate. Immunology. 2016;150:7–15. https://doi.org/10.1111/imm.12645.
Erny D, Prinz M. How microbiota shape microglia phenotypes and epigenetics. Glia. 2020;68:1655–72. https://doi.org/10.1002/glia.23822.
Kelly JR, Minuto C, Cryan JF, Clarke G, Dinan TG. Cross talk: The microbiota and neurodevelopmental disorders. Front Neurosci. 2017;11:490. https://doi.org/10.3389/fnins.2017.00490.
Holingue C, Budavari AC, Rodriguez KM, Zisman CR, Windheim C, Fallin MD. Sex differences in the gut-brain axis: implications for mental health. Curr Psychiatry Rep. 2020;22:83. https://doi.org/10.1007/s11920-020-01202-y.
Hao X, Pan J, Gao X, Zhang S, Li Y. Gut microbiota on gender bias in autism spectrum disorder. Rev Neurosci. 2021;32:69–77. https://doi.org/10.1515/revneuro-2020-0042.
Santos-Marcos JA, Haro C, Vega-Rojas A, Alcala-Diaz JF, Molina-Abril H, Leon-Acuna A, Lopez-Moreno J, Landa BB, Tena-Sempere M, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Camargo A. Sex differences in the gut microbiota as potential determinants of gender predisposition to disease. Mol Nutr Food Res. 2019;64:e1800870. https://doi.org/10.1002/mnfr.201800870.
Chen J-J, Zheng P, Liu Y-Y, Zhong X-G, Guo Y-J, Xie P. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:647–55. https://doi.org/10.2147/NDT.S159322.
Rogers GB, Keating DJ, Young RL, Wong M-L, Licino J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol Psychiatry. 2016;21:738–48. https://doi.org/10.1038/mp.2016.50.
Rincel M, Aubert P, Chevalier J, Grohard P-A, Basso L, de Oliveira CM, Helbling C, Levy E, Chevalier G, Leboyer M, Eberl G, Laye S, Capuron L, Vergnolle N, Neunlist M, Boudin H, Lepage P, Darnaudery M. Multi-hit early life adversity affects gut microbiota, brain and behavior in a sex-dependant manner. Brain Behav Immun. 2019;80:179–92. https://doi.org/10.1016/j.bbi.2019.03.006.
Li Y, Wei B, Liu X, Shen XZ, Shi P. Microglia, autonomic nervous system, immunity and hypertension: Is there a link? 2020b;155:104451. https://doi.org/10.1016/j.phrs.2019.104451.
Kopec AM, Fiorentino MR, Bilbo SD. Gut-immune-brain dysfunction in autism: Importance of sex. Brain Res. 2018a;1693:214–7. https://doi.org/10.1016/j.brainres.2018.01.009.
Amar AP, Weiss MH. Pituitary anatomy and physiology. Neurosurg Clin N Am. 2003;13:11–23. https://doi.org/10.1016/s1042-3680(02)00017-7.
Wilkinson M, Brown RE. An introduction to neuroendocrinology. 2nd ed. Cambridge (UK): Cambridge University Press; 2015.
Dorton AM. The pituitary gland: Embryology, physiology and pathophysiology. Neonatal Netw. 2000;19:9–17. https://doi.org/10.1891/0730-0832.19.2.9.
Dasen JS, Rosenfeld MG. Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci. 2001;24:327–55. https://doi.org/10.1146/annurev.neuro.24.1.327.
Kioussi C, Carriere C, Rosenfeld MG. A model for the development of the hypothalamic-pituitary axis: Transcribing the hypophysis. Mech Dev. 1999;81:23–35. https://doi.org/10.1016/S0925-4773(98)00229-9.
Musumeci G, Castorina S, Castrogiovanni P, Loreto C, Leonardi R, Concetta Aiello F, Magro G, Imbesi R. A journey through the pituitary gland: Development, structure and function, with emphasis on embryo-foetal and later development. Acta Histochem. 2015;117:355–66. https://doi.org/10.1016/j.acthis.2015.02.008.
Simerly RB. Wired on hormones: Endocrine regulation of hypothalamic development. Curr Opin Neurobiol. 2005;15:81–5. https://doi.org/10.1016/j.conb.2005.01.013.
Treier M, Rosenfeld MG. The hypothalamic-pituitary axis; co-development of two organs. Curr Opin Cell Biol. 1996;8:833–43. https://doi.org/10.1016/S0955-0674(96)80085-8.
Zhu X, Gleiberman AS, Rosenfeld MG. Molecular physiology of pituitary development: Signaling and transcriptional networks. Physiol Rev. 2007a;87:933–63. https://doi.org/10.1152/physrev.00006.2006.
Zhu X, Wang J, Ju B-G, Rosenfeld MG. Signaling and epigenetic regulation of pituitary development. Curr Opin Cell Biol. 2007b;19:605–11. https://doi.org/10.1016/j.ceb.2007.09.011.
Pearson CA, Placzek M. Development of the medial hypothalamus: Forming a functional hypothalamic-neurohypophyseal interface. Curr Top Dev Biol. 2013;106:49–88. https://doi.org/10.1016/B978-0-12-416021-7.00002-X.
Benarroch EE. Oxytocin and vasopressin: Social neuropeptides with complex neuromodulatory functions. Neurology. 2013;80:1521–18. https://doi.org/10.1212/WNL.0b013e31828cfb15.
Stoop R. Neuromodulation by oxytocin and vasopressin. Neuron. 2012;76:142–59. https://doi.org/10.1016/j.neuron.2012.09.025.
Stoop R. Neuromodulation by oxytocin and vasopressin in the central nervous system as a basis for their rapid behavioural effects. 2014. Curr Opin Neurobiol. 2014;29:187–93. https://doi.org/10.1016/j.conb.2014.09.012.
Bredewold R, Veenema AH. Sex differences in the regulation of social and anxiety-related behaviours: Insights from vasopressin and oxytocin brain systems. Curr Opin Neurobiol. 2018;49:132–40. https://doi.org/10.1016/j.conb.2018.02.011.
Francis SM, Sagar A, Levin-Decanini T, Lui W, Carter CS, Jacob S. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Res. 2014;1580:199–218. https://doi.org/10.1016/j.brainres.2014.01.021.
Penagarikano O. Oxytocin in animal models of autism spectrum disorder. Dev Neurobiol. 2017;77:202–2013. https://doi.org/10.1002/dneu.22449.
Ooi YP, Weng S-J, Kossowsky J, Gerger H, Sung M. Oxytocin and autism spectrum disorders: a systematic review and meta-analysis of randomized controlled trials. Pharmacopsychiatry. 2016;50:5–13. https://doi.org/10.1055/s-0042-109400.
Yamasue X, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Owada K, Yassin W, Kushima I, Benner S, Ogawa N, Eriguchi Y, Kawano N, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial. Mol Psychiatry. 2020;25:1849–58. https://doi.org/10.1038/s41380-018-0097-2.
Hornberg H, Perez-Garci E, Schreiner D, Hatstatt-Burkle L, Magara F, Baudouin S, Matter A, Nacro K, Pecho-Vrieseling E, Scheiffele P. Rescue of oxytocin response and social behaviour in a mouse model of autism. Nature. 2020;584:252–6. https://doi.org/10.1038/s41586-020-2563-7.
Nguyen TA, Lehr AW, Roche KW. Neuroligins and neurodevelopmental disorders: X-linked genetics. Front Synaptic Neurosci. 2020;12:33. https://doi.org/10.3389/fnsyn.2020.00033.
Andari E, Rilling JK. Genetic and epigenetic modulation of the oxytocin receptor and implications for autism. Neuropsychopharmacology. 2021;46:241–2. https://doi.org/10.1038/s41386-020-00832-3.
Baribeau DA, Dupis A, Paton TA, Scherer SW, Schacher RJ, Arnold PD, Szatmari P, Nicolson R, Georgiades S, Crosbie J, Brian J, Iaboni A, Lerch J, Anagnostou E. Oxytocin receptor polymorphisms are differentially associated with social abilities across neurodevelopmental disorders. Sci Rep. 2017;7:11618. https://doi.org/10.1038/s41598-017-10821-0.
Hernandez LM, Krasileva K, Green SA, Sherman LE, Ponting C, McCarron R, Lowe JK, Geschwind DH, Bookheimer SY, Dapretto M. Additive effects of oxytocin receptor gene polymorphisms on reward circuitry in youth with autism. Mol Psychiatry. 2017;22:1134–9. https://doi.org/10.1038/mp.2016.209.
Duan C, Allard J. Gonadotropin-releasing hormone neuron development in vertebrates. Gen Comp Endocrinol. 2020;292:113465. https://doi.org/10.1016/j.ygcen.2020.113465.
Kaprara A, Huhtaniemi IP. The hypothalamus-pituitary-gonad axis: tales of mice and men. Metabolism. 2018;86:3–17. https://doi.org/10.1016/j.metabol.2017.11.018.
Matsuda F, Ohkura S, Magata F, Munetomo A, Chen J, Sato M, Inoue N, Uenoyama Y, Tsukamura H. Role of kisspeptin neurons as a GnRH surge generator: comparative aspects in rodents and non-rodent mammals. J Obstet Gynaecol Res. 2019;45:2318–29. https://doi.org/10.1111/jog.14124.
Saedi S, Khoradmehr A, Reza M, Shirazi J, Tamadon A. The role of neuropeptides and neurotransmitters on kisspeptin/kiss1r-signaling in female reproduction. J Chem Neuroanat. 2018;92:71–82. https://doi.org/10.1016/j.jchemneu.2018.07.001.
Smith MJ, Jennes L. Neural signals that regulate GnRH neurons directly during the oestrous cycle. Reproduction. 2001;122:1–10. https://doi.org/10.1530/rep.0.1220001.
Tsukamura H, Homma T, Tomikawa J, Uenoyama Y, Maeda K. Sexual differentiation of kisspeptin neurons responsible for sex difference in gonadotropin release in rats. Ann NY Acad Sci. 2010;1200:95–103. https://doi.org/10.1111/j.1749-6632.2010.05645.x.
Son YL, Ubuka T, Tsutsui K. Molecular mechanisms of gonadotropin-inhibitory hormone (GnIH) actions in target cells and regulation of GnIH expression. Front Endocrinol. 2019;10:110. https://doi.org/10.3389/fendo.2019.00110.
Schafer D, Kane G, Colledge WH, Piet R, Herbison AE. Sex- and sub region-dependant modulation of arcuate kisspeptin neurones by vasopressin and vasoactive intestinal peptide. J Neuroendocrinol. 2018;30:e12660. https://doi.org/10.1111/jne.12660.
Ke R, Ma X, Lee LTO. Understanding the functions of kisspeptin and kisspeptin receptor (Kiss1R) from clinical case studies. Peptides. 2019;120:170019. https://doi.org/10.1016/j.peptides.2018.09.007.
Dode C, Hardelin J-P. Kallmann syndrome. Eur J Human Genet. 2009;17:139–46. https://doi.org/10.1038/ejhg.2008.206.
Abbara A, Eng PC, Phylactou M, Clarke S, Mills E, Chia G, Yang L, Izzi-Engbeaya C, Smith N, Jayasena C, Comninos AN, Anand-Ivell R, Rademaker J, Xu C, Quinton R, Pitteloud N, Dhillo WS. Kisspeptin-54 accurately identifies hypothalamic GnRH neuronal dysfunction in men with congenital hypogonadotropic hypogonadism. Neuroendocrinology. 2020; https://doi.org/10.1159/000513248.
Carpenter T, Grecian SM, Reynolds RM. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: A systematic review. J Dev Orig Health Dis. 2017;8:244–55. https://doi.org/10.1017/S204017441600074X.
Bangasser DA, Valentino RJ. Sex differences in stress-related psychiatric disorders: Neurobiological perspectives. Front Neuroendocrinol. 2014;35:303–19. https://doi.org/10.1016/j.yfrne.2014.03.008.
Nandem LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder-translating findings from humans to animal models and back. Front Psychiatry. 2020;10:974. https://doi.org/10.3389/fpsyt.2019.00974.
Heck AL, Handa RJ. Sex differences in the hypothalamic-pituitary-adrenal axis’ response to stress: an important role for gonadal hormones. Neuropsychopharmacology. 2019;44:45–58. https://doi.org/10.1038/s41386-018-0167-9.
Hodes RE. A primer on sex differences in the behavioural response to stress. Curr Opin Behav Sci. 2018;23:75–83. https://doi.org/10.1016/j.cobeha.2018.03.012.
Panagiotakopoulos L, Neigh GN. Development of the HPA axis: where and when do sex differences manifest? Front Neuroendocrinol. 2014;35:285–302. https://doi.org/10.1016/j.yfrne.2014.03.002.
Gifford RM, Reynolds RM. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans. Early Hum Dev. 2017;114:7–10. https://doi.org/10.1016/j.earlhumdev.2017.09.011.
Bangasser DA, Wiersielis KR. Sex differences in stress responses: a critical role for corticotropin-releasing factor. Hormones. 2018;17:5–13. https://doi.org/10.1007/s42000-018-0002z.
Rubinow DR, Schmidt PJ. Sex differences in the neurobiology of affective disorders. Neuropsychopharmacology. 2019;44:111–28. https://doi.org/10.1038/s41386-018-0148-z.
Bale TL. Epigenetic and transgenerational reprogramming of brain development. Nat Rev Neurosci. 2015;16:332–44. https://doi.org/10.1038/nrn3818.
Martin WN, Pennell CE, Wang CA, Reynolds R. Developmental programming and the hypothalamic-pituitary-adrenal axis. Curr Opin Endocr Metab Res. 2020;13:13–9. https://doi.org/10.1016/j.coemr.2020.07.010.
Abbink MR, van Deijk A-L, Heine VM, Verheijen MH, Korosi A. The involvement of astrocytes in early-life adversity induced programming of the brain. Glia. 2019;67:1637–53. https://doi.org/10.1002/glia.23625.
Bale TL. Sex differences in prenatal epigenetic programming of stress pathways. Stress. 2011;14:348–56. https://doi.org/10.3109/10253890.2011.586447.
Matthews SG, McGowan PO. Developmental programming of the HPA axis and related behaviours: Epigenetic mechanisms. J Endocrinol. 2019;242:T69–79. https://doi.org/10.1530/JOE-19-0057.
Kigar SL, Chang L, Guerrero CR, Sehring JR, Cuarenta A, Parker LL, Bakshi VP, Auger AP. N6-methyladenine is an epigenetic marker of mammalian early life stress. Sci Rep. 2017;7:18078. https://doi.org/10.1038/s41598-017-18414-7.
Garcia-Caceres C, Lagunas N, Calmarza-Font I, Azcoitia I, Diz-Chaves Y, Garcia-Segura LM, Baquedano E, Frago LM, Argente J, Chowen JA. Gender differences in the long-term effects of chronic prenatal stress on the HPA axis and hypothalamic structure in rats. Psychoneuroendocrinology. 2010;35:1525–35. https://doi.org/10.1016/j.psyneuen.2010.05.006.
Lei L, Wu X, Gu H, Ji M, Yang J. Differences in DNA methylation reprogramming underlie the sexual dimorphism of behavioural disorder caused by prenatal stress in rats. Front Neurosci. 2020;14:573107. https://doi.org/10.3389/fnins.2020.573107.
White JD, Arefin TM, Pugliese A, Lee CH, Gassen J, Zhang J, Kaffman A. Early life stress causes sex-specific changes in adult fronto-limbic connectivity that differentially drive learning. eLife. 2020;9:e58301. https://doi.org/10.7554/eLife.58301.
Hodes RE, Walker DM, Labonte B, Nestler EJ, Russo SJ. Understanding the epigenetic basis of sex differences in depression. J Neurosci Res. 2017;95:692–702. https://doi.org/10.1002/jnr.23876.
Eugene D, Djemli A, Van Vliet G. Sexual dimorphism of thyroid function in newborns with congenital hypothyroidism. J Clin Endocrinol Metab. 2005;90:2696–700. https://doi.org/10.1210/jc.2004-2320.
Calcaterra V, Nappi RE, Regalbuto C, De Silvestri A, Incardona A, Amariti R, Bassanese F, Clemente AM, Vinci F, Albertini R, Larizza D. Gender differences at the onset of autoimmune thyroid diseases in children and adolescents. Front Endocrinol. 2020;11:229. https://doi.org/10.3389/fendo.2020.00229.
Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51. https://doi.org/10.1093/bmb/ldr030.
Hashemipour M, Samei P, Kelishadi R, Hovsepian S, Zavareh NHT. A systemic review on the risk factors of congenital hypothyroidism. J Pediatr Rev. 2019;7:199–210. https://doi.org/10.32598/jpr.7.4.199.
Castello R, Caputo M. Thyroid diseases and gender. Ital J Gender Specific Med. 2019;5:136–41. https://doi.org/10.1723/3245.32148.
Merrill SJ, Mu Y. Thyroid autoimmunity as a window to autoimmunity: An explanation for sex differences in the prevalence of thyroid autoimmunity. J Theor Biol. 2015;375:95–100. https://doi.org/10.1016/j.jtbi.2014.12.015.
Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-pituitary-thyroid axis. Compr Physiol. 2016;6:1387–428. https://doi.org/10.1002/cphy.c150027.
Fleury Y, Van Melle G, Woringer V, Gaillard RC, Portmann L. Sex-dependant variations and timing of thyroid growth during puberty. J Clin Endocrinol Metab. 2001;86:750–4. https://doi.org/10.1210/jcem.86.2.7209.
Santin AP, Furlanetto TW. The role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011:875125. https://doi.org/10.4061/2011/875125.
Bauer M, Glenn T, Pilhatsch M, Pfennig A, Whybrow PC. Gender differences in thyroid system function: Relevance to bipolar disorder and its treatment. Bipolar Disorders. 2014;16:58–71. https://doi.org/10.1111/bdi.12150.
Wang C, Xu Y. Mechanisms for sex differences in energy homeostasis. J Mol Endocrinol. 2019;62:R129–43. https://doi.org/10.1530/JME-18-0165.
Wang B, Song R, He W, Yao Q, Li Q, Jia X, Zhang J. Sex differences in the associations of obesity with hypothyroidism and thyroid autoimmunity among Chinese adults. Front Physiol. 2018a;9:1397. https://doi.org/10.3389/fphys.2018.01397.
Christen T, Trompet S, Noordam R, van Klinken JB, van Dijk KW, Lamb HJ, Cobbaert CM, den Heijer M, Jazet IM, Jukema JW, Rosendaal FR, de Mutsert R. Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin. Peptides. 2018;107:25–31. https://doi.org/10.1016/j.peptides.2018.07.008.
Ahmed ML, Ong KKL, Morrell DJ, Cox L, Drayer N, Perry L, Preece MA, Dunger DB. Longitudinal study of leptin concentrations during puberty: Sex differences and relationship to changes in body composition. J Clin Endocrinol Metab. 1999;84:899–905. https://doi.org/10.1210/jcem.84.3.5559.
Thvilum M, Brandt F, Almind D, Christensen K, Heiberg Brix T, Hegedus L. Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study. 2014;24:802–8. https://doi.org/10.1089/thy.2013.0555.
Zhao S, Chen Z, Wang X, Yao Z, Lu Q. Increased prevalence with subclinical hypothyroidism in female hospitalized patients with depression. Endocrine. 2020; https://doi.org/10.1007/s12020-020-02490-3.
Villanger GD, Ystrom E, Engel SM, Longnecker MP, Pettersen R, Rowe AD, Reichborn-Kjennerud T, Aase H. Neonatal thyroid-stimulating hormone and association with attention-deficit/hyperactivity disorder. Paediatr Perinat Epidemiol. 2019;34:590–6. https://doi.org/10.1111/ppe.12643.
Mughal BB, Fini J-B, Demeneix BA. Thyroid-disrupting chemicals and brain development: an update. Endocr Connect. 2018;7:R160–86. https://doi.org/10.1530/EC-18-0029.
Boas M, Main KM, Feldt-Rasmussen U. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes. 2009;16:385–91. https://doi.org/10.1097/MED.0b013e3283305af7.
Rubin BS. Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011;127:27–34. https://doi.org/10.1016/j.jsbmb.2011.05.002.
MacKay H, Abizaid A. A plurality of molecular targets: the receptor ecosystem for bisphenol-A (BPA). Horm Behav. 2018;101:59–67. https://doi.org/10.1016/j.yhbeh.2017.11.001.
Goldsby JA, Wolstenholme JT, Rissman EF. Multi- and transgenerational consequences of bisphenol A on sexually dimorphic cell populations in mouse brain. Endocrinology. 2016;158:21–30. https://doi.org/10.1210/en.2016-1188.
Jocsak G, Ioja E, Sandor Kiss D, Toth I, Barany Z, Bartha T, Frenyo LV, Zsarnovszky A. Endocrine disruptors induced distinct expression of thyroid and estrogen receptors in rat versus mouse primary cerebellar cell cultures. Brain Sci. 2019;9:359. https://doi.org/10.3390/brainsci9120359.
Ghassabian A, Trasande L. Disruption in thyroid signaling pathway: A mechanism for the effect of endocrine-disrupting chemicals on child neurodevelopment. Front Endocrinol. 2018;9:204. https://doi.org/10.3389/fendo.2018.00204.
Li F, Yang F, Li D-K, Tian Y, Miao M, Zhang Y, Ji H, Yuan W, Liang H. Prenatal bisphenol A exposure, fetal thyroid hormones and neurobehavioral development in children at 2 and 4 years: a prospective cohort study. Sci Total Environ. 2020a;722:137887. https://doi.org/10.1016/j.scitotenv.2020.137887.
Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA. Sex-specific epigenetic disruption and behavioural changes following low-dose in utero bisphenol A exposure. PNAS. 2013;110:9956–61. https://doi.org/10.1073/pnas.1214056110.
Cariati F, Carbone L, Conforti A, Bagnulo F, Peluso SR, Carotenuto C, Buonfantino C, Alviggi E, Alviggi C, Strina I. Bisphenol A-induced epigenetic changes and its effects on the male reproductive system. Front Endocrinol. 2020;11:453. https://doi.org/10.3389/fendo.2020.00453.
Amir S, Shah STA, Mamoulakis C, Docea AO, Kalantzi O-I, Zachariou A, Calina D, Carvalho F, Sofikitis N, Makrigiannakis A, Tsatsakis A. Endocrine disruptors acting on estrogen and androgen pathways cause reproductive disorders through multiple mechanisms: A review. Int J Environ Res Public Health. 2021;18:1–20. https://doi.org/10.3390/ijerph18041464.
Cabrera OH, Gulvezan T, Symmes B, Quillinan N, Jevtovic-Todorovic V. Sex differences in neurodevelopmental abnormalities caused by early-life anesthesia exposure: a narrative review. Br J Anesth. 2020;124:e81–91. https://doi.org/10.1016/j.bja.2019.12.032.
Gasparoni A, Ciardelli L, De Amici D, Castellazzi AM, Autelli M, Bottino R, Polito E, Bartoli A, Rondini G, Chirico G. Effect of general and epidural anaesthesia on thyroid hormones and immunity in neonates. Paediatr Anaesth. 2002;12:59–64. https://doi.org/10.1046/j.1460-9592.2002.00752.x.
Perenc L, Guzik A, Podgorska-Bednarz J, Druzbicki M. Growth disorders in children and adolescents affected by syndromes or diseases associated with neurodysfunction. Sci Rep. 2019;9:16436. https://doi.org/10.1038/s41598-019-52918-8.
Benarroch EE. Insulin-like growth factors in the brain and their potential clinical implications. Neurology. 2012;79:2148–53. https://doi.org/10.1212/WNL.0b013e3182752eef.
Riikonen R. Insulin-like growth factors in the pathogenesis of neurological diseases in children. Int J Mol Sci. 2017;18:2056. https://doi.org/10.3390/ijms18102056.
Vahdatpour C, Dyer AH, Tropea D. Insulin-like growth factor 1 and related compounds in the treatment of childhood-onset neurodevelopmental disorders. Fron Neurosci. 2016;10:450. https://doi.org/10.3389/fnins.2016.00450.
Ittig S, Studerus E, Heitz U, Menghini-Muller S, Beck K, Egloff L, Leanza L, Andreou C, Riecher-Rossler A. Sex differences in prolactin levels in emerging psychosis: indication for enhances stress reactivity in women. Schizophr Res. 2017;189:111–6. https://doi.org/10.1016/j.schres.2017.02.010.
Labad J. The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders. Psychoneuroendocrinology. 2019;102:29–36. https://doi.org/10.1016/j.psyneuen.2018.11.028.
Aslam S. Endocrine events involved in puberty: a revisit to existing knowledge. Life Sci. 2020;1:37–48. https://doi.org/10.37185/LnS.1.1.43.
Tena-Sempere. Keeping puberty on time: Novel signals and mechanisms involved. Curr Top Dev Biol. 2013;105:299–329. https://doi.org/10.1016/B978-0-12-396968-2.00011-7.
Sanchez-Garrido MA, Tena-Sempere M. Metabolic control of puberty: roles of leptin and kisspeptins. Horm Behav. 2013;64:187–94. https://doi.org/10.1016/j.yhbeh.2013.01.014.
Kauffman AS. Sexual differentiation and the Kiss1 system: hormonal and developmental considerations. Peptides. 2009;30:83–93. https://doi.org/10.1016/j.peptides.2008.06.014.
Juraska JM, Willing J. Pubertal onset as a critical transition for neural development and cognition. Brain Res. 2017;1654:87–94. https://doi.org/10.1016/j.brainres.2016.04.012.
Meredith RM. Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders. Neurosci Behav Rev. 2015;50:180–8. https://doi.org/10.1016/j.neubiorev.2014.12.001.
Piekarski DJ, Johnson CM, Boivin JR, Thomas AW, Lin WC, Delevich K, Galarce EM, Wilbrecht L. Does puberty mark a transition in sensitive periods for plasticity in the associative cortex? Brain Res. 2017;1654:123–44. https://doi.org/10.1016/j.brainres.2016.08.042.
Vijayakumar N, Op de Macks Z, Shirtcliff EA, Pfeifer JH. Puberty and the human brain: Insights into adolescent development. Neurosci Biobehav Rev. 2018;92:417–36. https://doi.org/10.1016/j.neubiorev.2018.06.004.
Peper JS, Hulshoff Pol HE, Crone EA, van Honk J. Sex steroids and brain structure in pubertal boys and girls: a mini-review of neuroimaging studies. Neuroscience. 2011;191:28–37. https://doi.org/10.1016/j.neuroscience.2011.02.014.
Wierenga LM, Bos MGN, Schreuders E, Kamp FV, Peper JS, Tamnes CK, Crone EA. Unraveling age, puberty and testosterone effects on subcortical brain development across adolescence. Psychoneuroendocrinology. 2018;91:105–14. https://doi.org/10.1016/j.psyneuen.2018.02.034.
Ahmed EI, Zehr JI, Schulz KM, Lorenz BH, DonCarlos LL, Sisk CL. Pubertal hormones modulate the addition of new cells to sexually dimorphic brain regions. Nat Neurosci. 2008;11:995–7. https://doi.org/10.1038/nn.2178.
Martins-Afférri MP, Ferreira-Silva IA, Franci CR, Anselmo-Franci JA. LHRH release depends on Locus Coeruleus noradrenergic inputs to the medial preoptic area and median eminence. Brain Res Bull. 2003;61(5):521–7. https://doi.org/10.1016/s0361-9230(03)00190-4.
Garcia-Falgueras A, Pinos H, Collado P, Pasaro E, Fernandez R, Jordan CL, Segovia S, Guillamon A. The role of the androgen receptor in CNS masculinization. Brain Res. 2005;1035:13–23. https://doi.org/10.1016/j.brainres.2004.11.060.
Peper JS, Burke SM, Wierenga LM. Sex differences and brain development during puberty and adolescence. Handb Clin Neurol. 2020;175:25–54. https://doi.org/10.1016/B978-0-444-64123-6.00003-5.
Rehbein E, Hornung J, Poromaa IS, Derntl B. Shaping of the female human brain by sex hormones: a review. Neuroendocrinology. 2021;111:183–206. https://doi.org/10.1159/000507083.
Yanguas-Casas N. Physiological sex differences in microglia and their relevance in neurological disorders. Neuroimmunol Neuroinflammation. 2020;7:13–22. https://doi.org/10.20517/2347-8659.2019.31.
Villa A, Gelosa P, Castiglioni L, Cimino M, Rizzi N, Pepe G, Lolli F, Marcello E, Sironi L, Vegeto E, Maggi A. Sex-specific features of microglia from adult mice. Cell Rep. 2018;23:3501–11. https://doi.org/10.1016/j.celrep.2018.05.048.
Kopec AM, Smith CJ, Ayre NR, Sweat SC, Bilbo SD. Mircoglial dopamine receptor elimination defines sex-specific nucleus accumbens development and social behavior in adolescent rats. Nat Commun. 2018b;9:3769. https://doi.org/10.1038/s41467-018-06118z.
Clasadonte J, Prevot V. The special relationship: glia-neuron interactions in the neuroendocrine hypothalamus. Nat Rev Endocrinol. 2018;14:25–44. https://doi.org/10.1038/nrendo.2017.124.
Gegenhuber B, Tollkuhn J. Sex differences in the epigenome: a cause or consequence of sexual differentiation of the brain? Genes. 2019;10:432. https://doi.org/10.3390/genes10060432.
Gegenhuber B, Tollkuhn J. Signature of sex: sex differences in gene expression in the vertebrae brain. WIREs Dev Biol. 2020;9:e348. https://doi.org/10.1002/wdev.348.
Shi L, Zhang Z, Su B. Sex biased gene expression profiling of human brains at major developmental stages. Sci Rep. 2016;6:21181. https://doi.org/10.1038/srep21181.
Shalev D, Melamed P. The role of the hypothalamus and pituitary epigenomes in central activation of the reproductive axis at puberty. Mol Cell Endocrinol. 2020;518:111031. https://doi.org/10.1016/j.mce.2020.111031.
Walker DM, Zhou X, Cunningham AM, Lipschultz AP, Ramakrishnan A, Cates HM, Bagot RC, Shen L, Zhang B, Nestler EJ. Sex-specific transcriptional changes in response to adolescent social stress in the brain’s reward circuitry. Biol Psychiatry. 2021; https://doi.org/10.1016/j.biopsych.2021.02.964.
Acien P, Acien M. Disorders of sex development: classification, review, and impact on fertility. J Clin Med. 2020;9:3555. https://doi.org/10.3390/jcm9113555.
Bramswig J, Dubbers A. Disorders of pubertal development. Dtsch Arztebl Int. 2009;106:295–304. https://doi.org/10.3238/arztebl.2009.0295.
Sultan C, Gaspari L, Maimoun L, Kalfa N, Paris F. Disorders of puberty. Best Pract Res Clin Obstet Gynaecol. 2018;48:62–9. https://doi.org/10.1016/j.bpobgyn.2017.11.004.
Abbara A, Dhillo WS. Makorin rings the kisspeptin bell to signal pubertal initiation. J Clin Invest. 2020;130:3957–60. https://doi.org/10.1172/JCI139586.
Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Sants MG, Bianco SCD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJP, Mendonca BB, Kaiser UB, Latronico AC. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab. 2010;95:2276–80. https://doi.org/10.1210/jc.2009-2421.
Papadimitriou A, Chrousos GP. Reconsidering the sex differences in the incidence of pubertal disorders. Horm Metab Res. 2005;37:708–10. https://doi.org/10.1055/s-2005-870586.
Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol. 2014;35:272–84. https://doi.org/10.1016/j.yfrne.2014.04.003.
Becker JB, Chartoff E. Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacol Rev. 2019;44:166–83. https://doi.org/10.1038/s41386-018-0125-6.
Kokane SS, Perrotti LI. Sex differences and the role of estradiol in mesolimbic reward circuits and vulnerability to cocaine and opiate addiction. Front Behav Neurosci. 2020;14:74. https://doi.org/10.3389/fnbeh.2020.00074.
Stice E, Figlewicz DP, Gosnell BA, Levine AS, Pratt WE. The contribution of brain reward circuits to the obesity epidemic. Neurosci Biobehav Rev. 2013;37:2047–58. https://doi.org/10.1016/j.neubiorev.2012.12.001.
Culbert KM, Breedlove SM, Sisk CL, Burt SA, Klump KL. The emergence of sex differences in risk for disordered eating attitudes during puberty: A role for prenatal testosterone exposure. J Abnorm Psychol. 2013;122:420–32. https://doi.org/10.1037/a0031791.
Klump KL. Puberty as a critical risk period for eating disorders: a review of human and animal studies. Horm Behav. 2013;64:399–410. https://doi.org/10.1016/j.yhbeh.2013.02.019.
Evans JJ, Anderson GM. Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides. Hum Reprod Update. 2012;18:313–32. https://doi.org/10.1093/humupd/dms004.
Sominsky L, Jasoni CL, Twigg HR, Spencer SJ. Hormonal and nutritional regulation of postnatal hypothalamic development. J Endocrinol. 2018;237:R47–64. https://doi.org/10.1530/JOE-17-0722.
Timko AC, DeFilipp, Dakanalis A. Sex differences in adolescent anorexia and bulimia nervosa: Beyond the signs and symptoms. Curr Psychiatry Rep. 2019;21:1. https://doi.org/10.1007/s11920-019-0988-1.
Massa MG, Correa SM. Sexes on the brain: sex as multiple biological variables in the neuronal control of feeding. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165840. https://doi.org/10.1016/j.bbadis.2020.165840.
Valdearcos M, Douglass JD, Robblee MM, Dorfman MD, Stifler DR, Bennett ML, Gerritse I, Fasnacht R, Barres BA, Thaler JP, Koliwad SK. Microglial inflammatory signaling orchestrates the hypothalamic immune response to dietary excess and mediates obesity susceptibility. Cell Metab. 2017;26:185–97. https://doi.org/10.1016/j.cmet.2017.05.015.
Valdearcos M, Myers MG Jr, Koliwad SK. Hypothalamic microglia as potential regulators of metabolic physiology. Nat Metab. 2019;1:314–20. https://doi.org/10.1038/s42255-019-0040-0.
Harp SJ, Martini M, Lynch WJ, Rissman EF. Sexual differentiation and substance us: a mini-review. Endocrinology. 2020;161:1–9. https://doi.org/10.1210/endocr/bqaa129.
Kong G, Smith AE, McMahon TJ, Cavallo DA, Schepis TS, Desai RA, Potenza MN, Krishnan-Sarin S. Pubertal status, sensation-seeking, impulsivity, and substance use in high school–aged boys and girls. J Addict Med. 2013;7:116–21. https://doi.org/10.1097/ADM.0b013e31828230ca.
Kuhn C, Johnson M, Thomae A, Luo B, Simon SA, Zhou G, Walker QD. The emergence of gonadal hormone influences on dopaminergic function during puberty. Horm Behav. 2010;58:122–37. https://doi.org/10.1016/j.yhbeh.2009.10.015.
Calaprice D, Tona J, Parker-Athill EC, Murphy TK. A survey of pediatric acute-onset neuropsychiatric syndrome characteristics and course. J Child Adolesc Psychopharmacol. 2017;27:607–18. https://doi.org/10.1089/cap.2016.0105.
Ullsperger JM, Nikolas MA. A meta-analytic review of the association between pubertal timing and psychopathology in adolescence: are there sex differences in risk? Psychol Bull. 2017;143(9):903–38. https://doi.org/10.1037/bul0000106.
Donner NC, Lowry CA. Sex differences in anxiety and emotional behaviour. Pflugers Arch Eur J Physiol. 2013;465:601–26. https://doi.org/10.1007/s00424-013-1271-7.
van Keulen BJ, Dolan CV, van der Voorn B, Andrew R, Walker BR, Pol HH, Boomsma DI, Rotteveel J, Finken MJJ. Sexual dimorphism in cortisol metabolism throughout pubertal development: a longitudinal study. Endocr Connect. 2020;9:542–51. https://doi.org/10.1530/EC-20-0123.
Oyola MG, Handa RJ. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: Sex differences in regulation of stress responsivity. Stress. 2017;20:476–94. https://doi.org/10.1080/10253890.2017.1369523.
Gao R, Penzes P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med. 2015;15:146–67. https://doi.org/10.2174/1566524015666150303003028.
Goddings A-L, Beltz A, Peper JS, Crone EA, Braams BR. Understanding the role of puberty in structural and functional development of the adolescent brain. J Res Adolesc. 2019;29:32–53. https://doi.org/10.1111/jora.12408.
Juraska JM, Sisk CL, DonCarols LL. Sexual differentiation of the adolescent rodent brain: Hormonal influences and developmental mechanisms. Horm Behav. 2013;64:203–10. https://doi.org/10.1016/j.yhbeh.2013.05.010.
Ho SM, Cheong A, Adgent MA, Veevers J, Suen AA, Tam N, Leung YK, Jefferson WN, Williams CJ. Environmental factors, epigenetics, and developmental origin of reproductive disorders. Reprod Toxicol (Elmsford, N.Y.). 2017;68:85–104. https://doi.org/10.1016/j.reprotox.2016.07.011.
Murphy TK, Gerardi DM, Leckman JF. Pediatric acute-onset neuropsychiatric syndrome. Psychiatr Clin N Am. 2014;37:353–74. https://doi.org/10.1016/j.psc.2014.06.001.
Fausto-Sterling A. The five sexes. The Sciences. 1993;33:20–4. https://doi.org/10.1002/j.2326-1951.1993.tb03081.x.
Fausto-Sterling A. The five sexes, revisited. Sciences (New York). 2000;40:18–23. https://doi.org/10.1002/j.2326-1951.2000.tb03504.x.
Cools M, Nordenstrom A, Robeva R, Hall J, Westerveld P, Fluck C, Kohler B, Berra M, Springer A, Schweizer K, Pasterski V. Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat Rev Endocrinol. 2018;14:415–29. https://doi.org/10.1038/s41574-018-0010-8.
Witchel SF. Disorders of sex development. Best Pract Res Clin Obstet Gynaecol. 2018;48:90–102. https://doi.org/10.1016/j.bpobgyn.2017.11.005.
Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2:148–62. https://doi.org/10.1016/j.jpurol.2006.03.004.
Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006;118:e488-500. https://doi.org/10.1542/peds.2006-0738.
Bakula DM, Mullins AJ, Sharkey CM, Wolfe-Christensen C, Mullins LL, Wisniewski AB. Gender identity outcomes in children with disorders/differences of sex development: predictive factors. Semin Perinatol. 2017; https://doi.org/10.1053/j.semperi.2017.03.010.
Babu R, Shah U. Gender identity disorder (GID) in adolescents and adults with differences of sex development (DSD): a systematic review and meta-analysis. J Pediatr Urol. 2021;17:39–47. https://doi.org/10.1016/j.jpurol.2020.11.017.
Furtado PS, Moraes F, Lago R, Barros LO, Toralles MB, Barroso U Jr. Gender dysphoria associated with disorders of sex development. Nat Rev Urol. 2012;9:620–7. https://doi.org/10.1038/nrurol.2012.182.
Gonzalez R, Ludwikowski BM. Should CAH in females be classified as DSD? Front Pediatr. 2016;4:48. https://doi.org/10.3389/fped.2016.00048.
Costa R, Dunsford M, Skagerberg E, Holt V, Carmichael P, Colizzi M. Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. J Sex Med. 2015;12:2106–214. https://doi.org/10.1111/jsm.13034.
de Vries ALC, McGuire JK, Steensma TD, Wagenaar ECF, Doreleijers TAH, Cohen-Kettenis PT. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014;143:696–704. https://doi.org/10.1542/peds.2013-2958.
Kaltiala-Heino R, Bergman H, Työläjärvi M, Frisén L. Gender dysphoria in adolescence: current perspectives. Adolesc Health Med Ther. 2018;9:31–41. https://doi.org/10.2147/AHMT.S135432.
Zucker KJ. Adolescents with gender dysphoria: Reflections on some contemporary clinical and research issues. Arch Sex Behav. 2019;48:1983–92. https://doi.org/10.1007/s10508-019-01518-8.
Littman L. Rapid-onset gender dysphoria in adolescents and young adults: a study of parental reports. PLoS ONE. 2018;13:e0202330. https://doi.org/10.1371/journal.pone.0202330.
Littman L. Correction: Parent reports of adolescents and young adults perceived to show signs of a rapid onset of gender dysphoria. PLoS ONE. 2019;14:e0214157. https://doi.org/10.1371/journal.pone.0214157.
Hutchinson A, Midgen M, Spiliadis A. In support of research into rapid-onset gender dysphoria. Arch Sex Behav. 2019;49:70–80. https://doi.org/10.1007/s10508-019-01517-9.
Bao A-M, Swaab DF. Sexual differentiation of the human brain: Relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol. 2011;32:214–26. https://doi.org/10.1016/j.yfrne.2011.02.007.
Hahn A, Kranz GS, Kublbock M, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Winkler D, Kasper S, Windischberger C, Swaab DF, Lanzenberger R. Structural connectivity networks of transgender people. Cerebral Cortex. 2015;25:3527–34. https://doi.org/10.1093/cercor/bhu194.
Rajkowska G. Dysfunction in neural circuits involved in the pathophysiology of mood disorders. Biol Psychiatry. 2000;48:766–77.
Savic I, Garcia-Falgueras A, Swaab DF. Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Prog Brain Res. 2010;186:41–62. https://doi.org/10.1016/B978-0-444-53630-3.00004-X.
Smith ES, Junger J, Derntl B, Habel U. The transsexual brain—a review of findings on the neural basis of transsexualism. Neurosci Biobehav Rev. 2015;59:251–66. https://doi.org/10.1016/j.neubiorev.2015.09.008.
Boucher FJO, Chinnah TI. Gender dysphoria: a review investigating the relationship between genetic influences and brain development. Adolesc Health Med Ther. 2020;11:89–99. https://doi.org/10.2147/AHMT.S259168.
Garcia-Acero M, Moreno O, Suarez F, Rojas A. Disorders of sexual development: Current status and progress in the diagnostic approach. Curr Urol. 2019;13:169–78. https://doi.org/10.1159/000499274.
Ristori J, Cocchetti C, Romani A, Mazzoli F, Vignozzi L, Maggi M, Fisher AD. Brain sex differences related to gender identity development: Genes or hormones? Int J Mol Sci. 2020;21:2123. https://doi.org/10.3390/ijms21062123.
Taziaux M, Staphorsius AS, Ghatei MA, Bloom SR, Swaab DF, Bakker K. Kisspeptin expression in the human infundibular nucleus in relation to sex, gender identity, and sexual orientation. J Clin Endocrinol Metab. 2016;101:2380–9. https://doi.org/10.1210/jc.2015-4175.
Naule L, Maione L, Kaiser US. Puberty, a sensitive window of hypothalamic development and plasticity. Endocrinology. 2021;162:1–14. https://doi.org/10.1210/endocr/bqaa209.
Lopes-Ramos CM, Chen C-Y, Kuijer ML, Paulson JN, Sonawane AR, Fagny M, Platig J, Glass K, Quackenbush J, DeMeo DL. Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 2020;31:107795. https://doi.org/10.1016/j.celrep.2020.107795.
Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16(8):995–1004. https://doi.org/10.1101/gr.5217506.
Raznahan A, Disteche CM. X-chromosome regulation and sex differences in brain anatomy. Neurosci Biobehav Rev. 2021;120:28–47. https://doi.org/10.1016/j.neubiorev.2020.10.024.
Kassam I, Wu Y, Yang J, Visscher PM, McRae AF. Tissue-specific sex differences in human gene expression. Human Mol Genet. 2019;28:2976–86. https://doi.org/10.1093/hmg/ddz090.
Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-wide sex and gender differences in cancer. Front Oncol. 2020b;10:597788. https://doi.org/10.3389/fonc.2020.597788.
Brown RE. An introduction to neuroendocrinology. Cambridge (UK): Cambridge University Press; 1994.
Li Y, Dulac C. Neural coding of sex-specific social information in the mouse brain. Curr Opin Neurobiol. 2018;53:120–30. https://doi.org/10.1016/j.conb.2018.07.005.
de Vries GJ, Forger NG. Sex differences in the brain: a whole body perspective. Biol Sex Differ. 2015;6(15) https://doi.org/10.1186/s13293-015-0032-z.
American Psychiatric Association. 2013. The diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington DC: APA.
Ritchie H. Neurodevelopmental disorders . Website: https://ourworldindata.org/neurodevelopmental-disorders
National Organization of Rare Disorders: rare disease data base: https://rarediseases.org/rare-diseases/angelman-syndrome/
D'Souza HD, Karmiloff-Smith A. Neurodevelopmental disorders. WIREs Cogn Sci. 2017;8:e1398. https://doi.org/10.1002/wcs.1398.
Terasaki LS, Gomez J, Schwarz JM. An examination of sex differences in the effects of early-life opiate and alcohol exposure. Phil Trans R Soc Lond B Biol Sci. 2016;371(1688):20150123.
Adani S, Cepanec M. Sex differences in early communication development: behavioral and neurobiological indicators of more vulnerable communication system development in boys. Croat Med J. 2019;60(2):141–9.
Santangelo SL, Pauls DL, Goldstein JM, Faraone SV, Tsaung MT, Leckman JF. Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder? J Am Acad Child Adolesc Psychiatry. 1994;33(6):795–804.
Blume SR, Freedberg M, Vantrease JE, Chan R, Padival M, Record MJ, DeJoseph MR, Urban JH, Rosenkranz JA. Sex and estrus-dependant differences in rat basolateral amygdala. J Neurosci. 2017;37:10567–8. https://doi.org/10.1523/JNEUROSCI.0758-17.2017.
Ortega-Recalde O, Goikoetxea A, Hore TA, Todd EV, Gemmell NJ. The genetics and epigenetics of sex change in fish. Annu Rev Anim Biosci. 2020;8:47–69. https://doi.org/10.1146/annurev-animal-021419-083634.
Wade GN, Schneider JE, Li H-Y. Control of fertility by metabolic cues. Am J Physiol. 1996;270(Endocrinol. Metab. 33):E1–E19. https://doi.org/10.1152/ajpendo.1996.270.1.E1.
Acknowledgements
The author would like to thank Hiyam Gedalia, Kyle Roddick and Jessica Garden for their help in organizing this chapter and Dan Goldowitz for his editorial assistance.
Multiple-Choice Questions
-
1.
If a person has XXY sex chromosomes, they have the disorder A and will have the physical features of B
-
(a)
Turner’s syndrome; female
-
(b)
Klinefelter syndrome; male
-
(c)
Klinefelter syndrome; female
-
(d)
Congenital adrenal hyperplasia; female
-
(e)
Kallman syndrome; male
-
(a)
-
2.
During the prenatal critical period of development, the hormone A has the effect of B of the brain.
-
(a)
Testosterone; masculinization
-
(b)
Prolactin; masculinization
-
(c)
Testosterone; feminization
-
(d)
Progesterone; feminization
-
(e)
Corticosterone; masculinization
-
(a)
-
3.
The neuropeptide A regulates the secretion of the hypothalamic hormone B to regulate the sexual differentiation.
-
(a)
Substance P; GnRH
-
(b)
Galanin; CRH
-
(c)
CCK; TRH
-
(d)
Kisspeptin; GnRH
-
(e)
Kisspeptin; Oxytocin
-
(a)
-
4.
The area of the brain that regulates hormone secretion from the pituitary gland is
-
(a)
the prefrontal cortex
-
(b)
the amygdala
-
(c)
the hippocampus
-
(d)
the cerebellum
-
(e)
the hypothalamus
-
(a)
-
5.
Bisphenol A is a
-
(a)
neurotransmitter
-
(b)
neuropeptide
-
(c)
endocrine disruptor
-
(d)
hypothalamic hormone
-
(e)
anterior pituitary hormone
-
(a)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Brown, R.E. (2023). Sex Differences in Neurodevelopment and Its Disorders. In: Eisenstat, D.D., Goldowitz, D., Oberlander, T.F., Yager, J.Y. (eds) Neurodevelopmental Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-031-20792-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-20792-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-20791-4
Online ISBN: 978-3-031-20792-1
eBook Packages: MedicineMedicine (R0)